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From Neurons to Transcription Factors: the Biological Regulation of Aging 
By Peter Chisnell 
Abstract 
 Aging is a complex biological process that affects organisms ranging from humans to yeast, and 
understanding this process holds great potential for reducing the impact of age-related diseases such as 
heart disease, cancer, and neurodegenerative diseases. In this dissertation I explore both how neurons 
regulate lifespan and how two genes fundamental to the aging process interact with each other. First, I 
explore the neuronal regulation of lifespan. While we know that altering neuronal function can alter 
lifespan, the specific mechanisms by which neurons affect these changes, especially at the level of 
neuronal communication, remain to be elucidated. I show that reduction in signaling of the C. elegans 
ASI gustatory neuron pair through chemical silencing with tetanus toxin extends lifespan, likely primarily 
through reducing secretion of a TGFβ ligand (DAF-7), inhibiting the insulin-like signaling pathway, and 
activating the transcription factor DAF-16. Further results, such as a partial independence from daf-16, 
hint at a neuronal regulation of lifespan more complex than a sensory dial which increases or reduces 
DAF-7 levels.  
Second, I explore how the developmental arrest caused by reduction of activity of the 
fundamental lifespan gene heat shock factor 1 (hsf-1) can be rescued by loss of function of another 
gene, the ribosomal S6 kinase gene rsks-1. hsf-1, a regulator of the widely conserved heat-shock 
response, is not only essential for cellular stress resistance and adult longevity, but also for proper 
development. However, the genetic mechanisms by which heat-shock transcription factors regulate 
development are not well understood. I investigated how C. elegans strains derived from an unbiased 
genetic screen ameliorated the developmental-arrest phenotype of a heat-shock factor mutant. Here I 
show that loss of the conserved translational activator rsks-1/S6 Kinase, a downstream effector of mTOR 
kinase, can rescue the developmental-arrest phenotype of hsf-1 partial loss-of-function mutants. 
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Unexpectedly, I show that the rescue is not likely caused by reduced translation, nor by activation of any 
of a variety of stress-protective genes and pathways. My findings identify an as-yet unexplained 
regulatory relationship between the heat-shock transcription factor and the mTOR pathway during C. 
elegans’ development. 
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Chapter 1: An Introduction to Aging 
 Aging is a biological process that affects many organisms and has been studied in organisms as 
diverse as humans and yeast. The precise definition of aging changes slightly depending on the author 
and publication, but generally speaking, aging is an organism’s loss of normal physiological function and 
increase in mortality rate over time (Hayflick 2007; Flatt 2012). This loss of function can be measured at 
a cellular level of resolution by a variety of metrics, such as an increase in protein aggregation, 
dysregulation of cell membrane homeostasis, and alterations in organelle structure. In aggregate, these 
cellular dysfunctions lead to whole-organism deficits in organ function, immune function, mental acuity, 
and physical prowess, as well as an increase in risk for a variety of pathologies including heart disease, 
cancer, and neurodegenerative disease. As more and more people are living to older ages, these 
conditions constitute an increased burden on healthcare systems as well as an enormous human cost in 
the suffering they cause. An increased understanding of the biological mechanisms by which aging puts 
us at risk for these conditions may allow us to develop therapies to help people live longer lives in 
healthier bodies.  
 While aging and mortality have captivated humanity as far back as recorded history, as far as I 
can discern we have been exploring its genetic regulation since the turn of the 20th century. While it had 
been an anecdotal observation that longevity ran in families, in 1899 Mary Beeton and Karl Pearson 
published an analysis showing a positive correlation between the mean lifespan of fathers with sons and 
brothers with each other, suggesting that longevity is at least partially inherited (Beeton and Pearson 
1899). Throughout the twentieth century, investigations showed that not only is lifespan inherited, but 
that a variety of environmental factors can increase it above normal levels in multiple species. These 
investigations include how temperature affects the lifespan of Daphnia magna (MacArthur and Baillie 
1929), the effects of diet on flies (Glaser 1923), cockroaches (Haydak 1953), and rats (McCay et. al 1939; 
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Berg and Simms 1961), and the lifespan increase caused by castration, exercise, and mating in rats (Drori 
and Folman 1975), among many others. 
 Much of the interest in aging in the 20th century focused on rodents and humans, but after 
Syndey Brenner’s publication of “The genetics of Caenorhabditis elegans” in 1974, focus on the soil 
nematode dramatically increased. C. elegans are easily cultivated and genetically tractable; they have a 
small number of cells (959 in the hermaphrodite) with defined lineages, including a nervous system that 
produces a diversity of behaviors, and due to their size and translucent body can be easily analyzed via 
microscopy. Finally, and this is of great importance to the aging field, their median lifespan is 
approximately 15-20 days, which allows for much faster analysis of lifespan when compared to other 
organisms such as Drosophila (~2-3 months) or mice (~2 years). 
 In 1977, Michael Klass showed that C. elegans’ lifespans, like those of rodents and other 
organisms, can be regulated by altering the temperature at which they are cultivated and the amount of 
food they consume (Klass 1977). He later discovered multiple mutant strains of C. elegans which lived 
longer than wild-type animals, although each of his mutant strains showed significant defects in feeding 
and development due to paralysis of the pharynx or an unknown chemotactic defect causing the animals 
to avoid food (Klass 1983). Klass argued that the lifespan increase of these mutants was likely secondary 
to their reduction in food intake, a perturbation already shown to increase lifespan, and questioned 
whether any genes would be discovered to primarily affect aging. A few years later, Tom Johnson 
published that a strain from the original Klass screen, animals with a mutation in a gene he called age-1, 
had a 40% increased mean lifespan and showed apparently normal development, movement, and 
feeding, although the strain did have significantly reduced fertility (Friedman and Johnson 1987). In 
1993, Cynthia Kenyon published that a mutation in the gene daf-2 could double the lifespan of wild-type 
animals. At high temperatures, daf-2 mutant animals cause constitutive dauer formation, a long-lived 
developmental stage normally caused by stressful conditions, but the mutant showed extended lifespan 
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even at the permissive temperature. This mutation affected lifespan independently of reproduction, and 
it did not affect animal size, or feeding, providing yet more evidence that mutations which extended 
lifespan need not cause large-scale defects to normal physiology as Klass had observed. Kenyon et al. 
also found that the lifespan extension depended on the function of another gene, daf-16, showing that 
lifespan could be regulated concertedly by genetic pathways (Kenyon et al. 1993). 
 Later sequencing showed that daf-2 had sequence similarity to the mammalian insulin receptor 
and insulin-like growth factor (IGF-1) receptor (Kimura et al. 1997) and daf-16 encoded a FOXO-family 
transcription factor (Lin et al. 1997; Ogg et al. 1997), placing both daf-2 and daf-16 in the context of the 
larger insulin and insulin-like growth factor signaling pathway (IIS; reviewed by van Heemst 2010 as well 
as Murphy and Hu 2013).  While the IIS pathway has many components and outputs, a simplified 
scheme for how it affects lifespan is as follows: in natural conditions, insulin-like peptides (ILPs), 
primarily expressed in neurons, bind to and either activate (Pierce et al. 2001) or inhibit (Murphy et al. 
2007) DAF-2 activity. Activation of DAF-2 then causes the activation of AGE-1, a phosphoinositide 3-
kinase, which in turn causes the activation of PDK-1, a phosphoinositide-dependent kinase, which 
activates AKT-1, a serine/threonine protein kinase. Finally, AKT-1 phosphorylates and inactivates DAF-
16, which activates many protective genes and represses a variety of growth-related genes. In short, 
mutations of daf-2 cause a decrease in DAF-2 signaling, thereby activating DAF-16 and increasing 
lifespan. 
 A reduction in IIS signaling was the first genetic pathway described to modify lifespan, but it is 
far from the only pathway. Upon genetic analysis, most of these pathways seem to fit into a similar 
structure: an upstream signal or perturbation activates a signaling cascade which eventually activates 
one or more transcription factors necessary for the lifespan phenotype. Differing upstream changes will 
result in a different strength of phenotype: for instance daf-2 mutations extend lifespan more than akt 
mutations (Alam et al. 2010), but in both cases loss of daf-16 transcription factor function will cause the 
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entire effect to be lost no matter the upstream change. This pattern is true of the lifespan extension 
caused by reduced mTOR signaling, which requires the function of the FoxA transcription factor PHA-4 
(Sheaffer et al. 2008), loss of germ cells, which requires the activity DAF-12 (Hsin and Kenyon, 1999), 
reduced respiration, which requires HIF-1 activity (Lee et al. 2010), and dietary restriction, which 
requires differing transcription factors depending on the precise method of restriction (Kenyon 2010). 
This is not an exhaustive list, as many of these pathways require multiple transcription factors. For 
instance, loss of germ cells also requires the function of DAF-16 (Hsin and Kenyon 1999), and both a 
reduction in IIS signaling and mTOR signaling at least partially require the function of the mammalian Nrf 
homolog SKN-1 (Tullet et al. 2008; Robida-Stubbs et al. 2012). While there is overlap in the transcription 
factors which are necessary to extend lifespan, these pathways are considered separate or at least 
partially separate because they interact additively. For example, a loss of germ cells and a mutation in 
daf-2 extend lifespan further than either perturbation alone (Hsin and Kenyon 1999). 
 The experiments referenced above were all conducted in C. elegans, but the major pathways 
which regulate lifespan are conserved across species.  Many of the pathways discussed above have been 
found to regulate lifespan in multiple organisms, including flies, fish, and rodents. A few interventions, 
such as dietary restriction, have been tested more widely and even have beneficial effects in primates 
(Colman et al. 2009; Mattison et al. 2012). While we cannot directly experiment with human genetics, 
genetic analysis of long lived humans often reveals DNA variants in genes in the IIS pathway (Kenyon 
2010). Otin et al. organized these shared aging pathways into what they called the nine “hallmarks of 
aging,” which they classified as genomic instability, telomere attrition, epigenetic alterations, loss of 
proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell 
exhaustion, and altered intercellular communication. Focusing on mammals, they considered something 
a hallmark if “(1) it should manifest during normal aging; (2) its experimental aggravation should 
accelerate aging; and (3) its experimental amelioration should retard the normal aging process and 
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hence increase healthy lifespan.” This highly conserved nature of lifespan regulation allows for 
investigation to proceed in multiple organisms according to their particular advantages with the 
knowledge that the knowledge derived from one will in all likelihood be applicable to another. 
 While many of the basic underpinnings of the aging process have been worked out, there is 
much more for us to discover. While we classify pathways based on their requirements for specific 
transcription factors and additive lifespan effects, there is vast and recurrent crosstalk between 
pathways that could be understood at a greater resolution. Perturbations that increase lifespan can also 
be tied intimately to metabolic regulation, fertility, and immune and stress responses. While in some 
instances these can be separated, it is important to understand the multifaceted functions that genes in 
these pathways play, especially as we attempt to invent human health interventions. To compound this 
complexity, all of these systems change their regulation with age and are affected differently in different 
tissues which themselves signal to one another. All of these complexities are exciting and important 
directions for future investigations to more fully understand how an organism ages. 
 During my thesis work at UCSF, I engaged in two projects investigating different aspects of 
aging. The first, discussed in detail in Chapter 2, was an effort to tease apart the mechanism by which a 
single pair of neurons responsible for tasting the environment can regulate lifespan. The nervous system 
reacts dynamically to both internal and external sensory queues and directs whole-body responses to 
them, including responses which can increase lifespan. In Chapter 3, I use the power of genetics to 
discover how a mutation incompatible with life can be resisted and explore the previously unknown 
cellular channel of communication that mediates this resistance.  
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Chapter 2: How Neurons Regulate Lifespan 
Introduction: 
 The longevity of an organism can be regulated by its sensory nervous system. This finding was 
first shown in 1999 when Javier Apfeld published that mutant C. elegans with widespread dysfunction in 
their sensory system lived much longer than controls.  Lifespan increases were seen in a multitude of 
mutants, eleven of which caused disruption to cilia, which are required for the vast majority of sensory 
neurons to function, and four of which caused various deficits in sensation by neurons within the 
amphid, the primary sensory organ of C. elegans. Apfeld further showed that reducing sensory input to 
the animal via the laser-ablation of the amphid sheath cell could also increase the lifespan of an 
otherwise genetically normal animal. While the various methods of sensory disruptions had a large 
effect on lifespan, they did not have a measurable effect on development, growth, feeding, or 
reproduction, suggesting that it is not an obvious large-scale change in physiology but a lack of sensory 
input per se that increases lifespan. The lifespan increase largely required the function of daf-16/FOXO, 
and did not further extend the lifespan of daf-2 mutants, suggesting that sensory input modifies lifespan 
through altering signaling in the IIS pathway. 
 While the neuronal regulation of lifespan was first discovered in C. elegans, it is by no means 
unique to that organism (Alcedo et. al 2013). Mutant Drosophila with olfactory defects show an 
increased lifespan (Libert et al. 2007), and mice with a genetically-overheated hypothalamus showed 
increased lifespan without an effect on caloric intake (Conti et al. 2006). Nervous systems are 
responsible for sensing and reacting to both changes in external conditions as well as internal state, and 
understanding how these processes impact health and longevity may have wide-spread implications for 
understanding and intervening in the variety of deleterious human health conditions that occur with 
age.  A unique advantage to studying the neuronal regulation of lifespan in C. elegans is that instead of 
having neuronal nuclei made up of thousands of neurons to perform a function, each nematode has 302 
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neurons, bilateral pairs of which are largely responsible entire functions on their own. Fully 
understanding this simpler system may give us an understanding of the basic inputs and outputs that 
are being regulated by much larger groups of neurons in other organisms. 
 In C. elegans, even single pairs of neurons can have detectable effects on lifespan. At the 
ambient oxygen concentration of 20%, loss of the BAG neuron pair, which detects low levels of oxygen, 
can increase lifespan, whereas loss of the URX neuron pair, which detects high levels of oxygen, can 
decrease lifespan (Liu and Cai 2013). Further investigation proved these effects were dependent upon 
oxygen concentration, showing normal URX function is to increase lifespan in response to high oxygen 
whereas BAG decreases lifespan in response to low oxygen. These neuronal effects on lifespan oppose 
the normally toxic effects of high oxygen concentration and beneficial effects of low oxygen 
concentration on lifespan, suggesting that animals compensate for environmental change to maintain a 
specific length of life.  
 While the lifespan-effects of BAG and URX antagonize each other, they seem to be 
mechanistically separable, mediated through different guanylate cyclases and with no known common 
downstream target. In contrast, some neurons affect lifespan in concert with other neurons. For 
instance, the ablation of the olfactory neuron pair AWA causes a small increase in mean lifespan (11%), 
and the ablation of another olfactory neuron pair AWC has no significant effect on lifespan, but if both 
are ablated there is a larger lifespan increase than either alone (26%). Similarly, the ablation of the 
gustatory neuron pair ASI increases mean lifespan by 19%, and the ablation of the gustatory neuron pair 
ASJ has no significant effect on lifespan, but if both are ablated together then animals no longer show an 
increased lifespan. As was the case with the widespread sensory reduction experiments from Apfeld et 
al., daf-16/FOXO was partially required for lifespan increase caused by olfactory-neuron ablation and 
fully required in the case of gustatory-neuron ablation (Alcedo and Kenyon 2004), suggesting that 
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sensory input on multiple neurons is somehow integrated and transmitted into a whole-organism 
response through cell-nonautonomous activation of daf-16. 
 Ablation of ASI is likely to be increasing lifespan through a loss of daf-7/TGFβ signaling. ASI is the 
only neuron which expresses daf-7/TGFβ under normal experimental conditions (Meisel et al. 2014), and 
mutation of daf-7/TGFβ causes an increase in lifespan (average mean increase of 23.8% over 6 
replicates, max 39.3%) (Shaw et al. 2007) through signaling to downstream transcription factors daf-
3/SMAD and daf-16/FOXO. Consistent with this, Shaw et al. also showed that daf-7/TGFβ mutation 
increases DAF-16 localization to the nucleus and the expression of the DAF-16-target gene sod-3, two 
measurements of DAF-16 activity.  
 While neuronal ablation can have lifespan effects specific to the presence or absence of other 
neurons, the signals that are mediating these effects and whether those effects are truly a matter of 
neuronal communication has yet to be explored. In this chapter I will discuss the first half of my thesis 
work where I investigated the connection between the neurons ASI and ASJ and lifespan. I show that a 
transgenic strain expressing tetanus toxin specifically in ASI, a perturbation which should disrupt 
(silence) chemical signaling from ASI, exhibits an increase in lifespan much like animals subjected to 
ablation of the neuron pair. I further show that this silencing effect increases expression of the DAF-16-
target gene sod-3. Interestingly, this increase did not require daf-16 or daf-3. Further investigation of 
the genetic epistasis of the lifespan phenotype was complicated by lack of replicability of the phenotype, 
especially in a strain in which the transgenic construct had been integrated into the genome. This 
difficulty was not resolved by the use of automated lifespan machines, even though they have a 48x 
increase in resolution over by-hand lifespan assays. Despite these difficulties, I will argue that both 
silencing of ASI and ablation of ASI are similar in that they fully require the function of daf-3 to increase 
lifespan, and the majority of their lifespan increase, but perhaps not all, is also mediated through daf-16. 
My studies re-emphasize that perturbation of single gustatory neuron pairs can cell-nonautonomously 
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modify whole-animal physiology to increase lifespan. In addition, differences measured between 
ablation and silencing of neurons as well as differences with the daf-7 mutation provide clues that the 
neuronal regulation of lifespan is likely more complicated than the regulation of a single secreted factor. 
Finally, my studies are also a cautionary tale showing that deeper dissection of small increases in 
lifespan can be hampered by the inherent stochasticity in the length of C. elegans lifespan. 
 
Methods and Materials: 
C. elegans strains 
 Wild-Type (N2) 
CF4126: muEx641[pPC30(pgpa-4::GFP::Tetx) + punc-122::RFP] 
CF4138: muIs84 [pAD76(psod-3::GFP)]; muEx641 [pPC30(pgpa-4::GFP::Tetx) + punc-122::RFP] 
 CF4152: daf-16(mu86)I; muEx641[Punc-122::RFP + pPC30(Pgpa-4::GFP::Tetx)] 
 CF4153: kri-1(ok1251)I; muEx541[Punc-122::RFP + pPC30(Pgpa-4::GFP::Tetx)] 
CF4154: muEx642[pPC31 (Ptrx-1::GFP::Tetx) + Podr-1::RFP]  
CF4170: daf-16(mu86)I; muIs84[pAD76(sod-3::gfp)]; muEx641[Punc-122::RFP + pPC30(Pgpa-
4::GFP::Tetx)] 
CF4171: kri-1(ok1251)I; muIs84[pAD76(sod-3::GFP)]; muEx541[Punc-122::RFP + pPC30(Pgpa-
4::GFP::Tetx)] 
CF4172: daf-3(mgDF90)X; muIs84[pAD76(sod-3::GFP)]; muEx541[Punc-122::RFP + pPC30(Pgpa-
4::GFP::Tetx)] 
CF4281: oyIs84 [Pgpa-4::TU#813 + Pgcy-27::TU#814 + Pgcy-27::GFP + Punc-122::DsRed] 
CF4282: muIs224[Pgpa-4::GFP::Tetx + Punc-122::RFP] 
CF4283: muIs225 [Ptrx-1::GFP::Tetx + Podr-1::RFP] 
CF4284: muIs224[Pgpa-4::GFP::Tetx + Punc-122::RFP]; [rec caspases under Pgpa-4, Pgcy-27 + 
Pgcy-27::GFP] 
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CF4285: muIs225 [Ptrx-1::GFP::Tetx + Podr-1::RFP]; [rec caspases under Pgpa-4, Pgcy-27 + Pgcy-
27::GFP] 
CF4286: N2E; muIs224[Pgpa-4::GFP::Tetx + Punc-122::RFP]; muIs225[Ptrx-1::GFP::Tetx + Podr-
1::RFP] 
 
 Dauer assay 
 Adult animals were allowed to lay eggs at 20°C for 2-3 hours, after which adults were removed 
and eggs were incubated at 25°C for 48 hours. Animals were then washed off plates and incubated for 1 
to 2 hours in 1% SDS, which is lethal to non-dauer animals. After incubation the animals were washed, 
re-plated, and kept at 15°C overnight before being scored as dauers or non-dauers. 
 
sod-3 expression assay 
Animals collected from the same plate were divided into experimental or control conditions 
based on expression or lack thereof of RFP. Animals were then paralyzed with 10mM levamisole for 10 
minutes, corralled together into rows, and then imaged at 50x under bright field and to measure GFP 
fluorescence. Images contained ~5 animals per image. Light level and exposure time (108ms) were 
selected so as to provide the brightest pictures without any saturation and were kept constant both 
within and across experiments. To analyze the images in as unbiased a manner as possible, the entire 
body of each animal was outlined under a brightfield image in imageJ and then the average intensity of 
that outline was measured in the corresponding fluorescent image. A large section of the background 
fluorescence was measured and this number was subtracted from all measurements. Significance was 
measured by comparing the control and experimental group utilizing a two-tailed t-test. While the 
tetanus toxin construct itself was bound to GFP, the intensity of that construct was exceedingly dim and 
we required the use of an RFP co-injection marker to separate Tetx-expressing animals from controls at 
magnifications of 50x and lower. In addition, the increase in expression was not restricted to the ASI 
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neuron pair alone but also appeared throughout the head as well as the nerve cord, parts of the vulva, 
and the tail, all locations the psod-3::GFP construct is expressed under control conditions (Libina et al. 
2003). Due to both these pieces of evidence, we conclude that the increased GFP measured is due to the 
effects of tetanus toxin in ASI. 
 
RNAi:  
HT-115 RNAi bacteria were obtained from existing Ahringer and Vidal libraries, or in the case of 
daf-16 RNAi a clone created in the Dillin lab was used. The control for all RNAi experiments was L4440 
vector. For each experiment, single colonies were grown overnight at 37°C in 3 mL LB with 100µg/mL 
carbenicillin and 10µg/mL tetracycline. The next day, the resulting stationary-phase cultures were 
diluted tenfold with LB containing 100µg/mL carbenicillin and grown for two hours at 37°C. 1M IPTG was 
then added to the culture to reach a final concentration of 2mM, after which 100µL of the resulting 
culture were spotted onto NGM plates. The bacteria were grown on these plates overnight at 30°C. 
Animals were placed on plates the following day in all experiments except those involving a drug 
condition, in which case drugs were added and left to diffuse into the plate for an additional day before 
the addition of experimental and control animals.  
 
Real-time qPCR: 
RNA extraction, cDNA preparation, and real-time qPCR were performed as described previously 
(Van Gilst et al. 2005) from 1 biological replicate of each condition animals were grown to young 
adulthood before being washed and flash-frozen for RNA extraction. Data were standardized to a 
tubulin control primers.  
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Statistical Analyses: 
On all dot plots and bar graphs, bars represent the mean, and error bars represent the SEM. For 
lifespan assays, log-rank tests were used to test for significance. For sod-3 expression experiments, a 
two-tailed Student’s t-test was used to test for significance.  
 
Lifespan Analysis: 
Life span analysis was performed at 20°C as described previously (Apfeld and Kenyon 1998). 
Animals were grown on OP50 E. coli or HT-115 RNAi bacteria and transferred to fresh plates on the first 
day of adulthood (“day 1”) and every 2 days thereafter. Every two days, starting on day 1, animals were 
scored. Animals that moved were scored as alive, animals that did not move, even after being prodded 
with a platinum wire, were scored as dead, and animals that could not be found or displayed 
phenotypes such rupturing or bagging were censored. 
 
Results: 
Silencing the gustatory neuron pair ASI increases lifespan 
 To test whether disrupting the signaling of ASI, as opposed to ablating it entirely, could increase 
lifespan, I expressed the tetanus toxin light chain (Tetx) under the ASI-specific promoter pgpa-4 (Figure 
2.1 A; Jansen et al. 2004). Tetanus toxin silences, or disrupts, neurotransmission by blocking the release 
of both small clear-core vesicles and large dense-core vesicles, but should not affect communication 
through gap junctions, which do not require vesicles to transmit electrical current (Schiavo et al. 1992; 
McMahon et al. 1992). The stochastic inheritance of the transgenic construct caused adults expressing 
the construct to produce progeny with and without Tetx in ASI. This allowed for comparison of animals 
raised to adulthood on the same plates and produced by the same group of parents. Tetx in ASI 
significantly extended lifespan in otherwise wild-type animals across five replicates, with median 
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lifespan increasing by an average of 14.9% (Figure 2.1 B, C). All lifespans discussed in this section are 
recorded in Table 2.1.  
In order to reduce variance in the lifespan measure, more efficiently cultivate and select animals 
for experiments, and lay the groundwork for more complicated experiments involving both ASI and ASJ, 
I integrated the extrachromosomal array expressing Tetx in ASI into the animals’ linear DNA via UV 
radiation. Unfortunately, after backcrossing, this strain tended to have a smaller lifespan increase than 
the extrachromosomal strain from which it was derived. Across five replicate experiments, the average 
increase in median lifespan was only 9.8%, and only three out of the five experiments yielded 
statistically significant results between wild-type and Tetx strains by the log-rank test (Figure 2.1 D).  
 
The automated lifespan machine  
 As a part of my thesis work I constructed and operated automated lifespan machines 
(Stroustrup et al. 2013). These machines scan sixteen plates of animals once each hour over the course 
of a lifespan experiment. These machines not only allow a large number of experiments to be run 
simultaneously, but they also produce higher-resolution measurements (Figure 2.1 B vs. C) and better 
statistical power. Constructing the machines required me to physically modify the chassis and 
recalibrate the focal length of commercially available scanners as well as laser-cutting rubber sheets to 
hold plates of worms in position on glass plates precisely. They also required managing communication 
between multiple computers to run the scanners, store the data, and analyze the results. The 
instructions for modifying the scanners and the software used to run them and analyze the results were 
all created by Stroustrup et al.; still, implementation of them in the Kenyon lab was a substantial project. 
The machines were effective and useful, however some software issues (such as scanners spontaneously 
stopping) and rubber sealing issues (resulting in desiccated plates) remained chronic barriers that 
needed to be managed. 
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Figure 2.1: Silencing the ASI neuron extends lifespan. (A) Image of the pgpa-4::Tetx::GFP construct 
expressed only in the ASI neuron pair, 600x magnification. (B) Tetx in ASI increases lifespan, measured 
by the automated lifespan machine, p<0.0001 by log-rank test. (C) Tetx in ASI increases lifespan, 
measured by hand, p=0.0125 by log-rank test. (D) Plots of the normal distributions of percent increase in 
median lifespan of Silenced ASI vs. wild-type. The two plots represent two strains, one that expresses 
the Tetx construct through an extrachromosomal array, and the other in which that array has been 
integrated into the genome (mean and standard deviation based on five replicates for each strain).  
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Silencing ASI increases expression of the daf-16-target gene sod-3 
 The extended lifespan caused by ablation of ASI requires the function of daf-16 (Alcedo and 
Kenyon 2004). I tested to see if silencing ASI increased the expression of any daf-16-target genes, both 
to determine if daf-16 was activated by silencing ASI with Tetx as well as to develop an assay, faster than 
lifespan assays, to explore the genetic epistasis of effects caused by silencing ASI. A preliminary RT-qPCR 
experiment revealed that silencing ASI increased expression of sod-3 and mtl-1 but not that of another 
DAF-16-regulated gene, dod-8. These changes in expression were lower in all cases than the increase 
produced by ablation of ASI (Figure 2.2). Because sod-3 showed the highest increase in response to the 
silencing of ASI, I then tested if this effect could be seen with a transcriptional fluorescent reporter by 
silencing ASI in a strain that expressed GFP under the sod-3 promoter. Tetx in ASI caused a significant 
increase in sod-3 expression under these conditions (Figure 2.3 A,B), but surprisingly this did not require 
DAF-16 or DAF-3 activity (Figure 2.3 C, D). The kri-1(ok1251) null mutation, which prevents the lifespan 
extension of germline-defective animals but not daf-2 mutants, also had no effect on sod-3 expression 
(Figure 2.3 E). The quantifications shown are for whole-body fluorescence, but similar trends were seen 
when only the head or only the anterior intestine were quantified (data not shown). All sod-3 
experiments were conducted with an extrachromosomal Tetx construct. 
 
Silencing of ASI, rather than ablating ASI, partially reduces the requirement of daf-16/FOXO 
 Because silencing ASI did not require the function of daf-16 or daf-3 to increase the expression 
of sod-3, I wondered if these genes were also dispensable for the lifespan phenotype. I tested the 
lifespan-effects of daf-16 RNAi on both silenced and ablated-ASI conditions as well as the lifespan-effect 
of the null mutation daf-16(mu86) on the silenced ASI strain (Figure 2.4). In all cases, I found that daf-16 
mutants exhibited the expected reduction of lifespan when compared with the wild type condition (an 
average 22.7% reduction in median lifespan). In two experiments, I tested the lifespan-effects of  
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Figure 2.2: Ablation, more than silencing, of ASI increases expression of daf-16-target genes. (A) 
Ablation of ASI increases expression of sod-3, dod-8, and mtl-1 in a single RT-qPCR experiment. (B) Tetx 
in ASI increases expression of sod-3 and mtl-1 but non dod-8 in a single RT-qPCR experiment. 
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Figure 2.3: Silencing ASI increases sod-3 expression independently of daf-16, daf-3, or kri-1. (A) Image of 
the increase in sod-3 expression caused by silencing of ASI, 50x magnification. (B) Silencing ASI 
significantly increases whole-body psod-3::GFP fluorescence in a wild-type background, ***p<0.001 by 
Student’s t-test. (C) Silencing ASI significantly increases whole-body psod-3::GFP fluorescence in a daf-
16(mu86) null background, ***p<0.001 by Student’s t-test. (D) Silencing ASI significantly increases 
whole-body psod-3::GFP fluorescence in a daf-3(mgDF90) null background, ***p<0.001 by Student’s t-
test. (E) Silencing ASI significantly increases whole-body psod-3::GFP fluorescence in a kri-1(ok1251) null 
background, ***p<0.001 by Student’s t-test. 
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Figure 2.4 The effects of silencing and ablating ASI in daf-16 reduction of function conditions. (A) Neither 
ablation nor silencing of ASI (integrated strain) increase lifespan in animals grown on daf-16 RNAi by log 
rank test. (B) Both ablation and silencing of ASI (integrated strain) significantly increase the lifespan of 
animals grown on daf-16 RNAi, p<0.03 by log-rank test before multiple comparisons. (C) Silencing ASI in 
animals grown on daf-16 RNAi significantly increases lifespan, p<0.001 by log-rank test before multiple 
comparisons. (D) Silencing ASI in the daf-16(mu86) null background significantly extends lifespan, 
p<0.001 by log-rank test.  
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ablating ASI in animals grown on daf-16-RNAi bacteria. These experiments yielded mixed results, with 
one showing no significant difference and the other a significantly different lifespan curve with a 4% 
increase in median lifespan (Figure 2.4 A, B). Across seven replicates, I found that silencing ASI in a daf-
16 null background or in animals grown on daf-16 RNAi produced a significant difference in lifespan in 
four, or just over half, of the cases with an average increase in median lifespan of 6.5% (Figure 2.4 A-D). 
The lack of reproducibility is likely explained by the drastic reduction in lifespan increase when 
compared with conditions in which DAF-16 function is normal. Because there is still often a detectable 
difference, I argue that signaling through daf-16 mediates most of the lifespan increase of silencing ASI 
but not the entirety of it. I did not conduct enough experiments in which ASI was ablated to know if the 
very small but significant increase in lifespan in one of two experiments was due to random chance, or if 
ablation of ASI also has a partially daf-16-independent increase in lifespan. 
 
Both silencing and ablation of ASI require daf-3/SMAD to increase lifespan 
 While silencing and ablation of ASI may not entirely require the function of daf-16/FOXO to 
extend lifespan lifespan, their lifespan-extension phenotypes both fully required the function of daf-
3/SMAD, a transcription factor required for daf-7/TGFβ mutation to increase lifespan. In no experiments 
did I see a significant increase in reduced-ASI function over wild type lifespan in daf-3-reduction-of-
function backgrounds (Figure 2.5 A,B).  
 
Activity of KRI-1 is not required for silencing of ASI to increase lifespan 
 ASI ablation has been shown to reduce the number of germ cells in C. elegans (Dalfó et al. 
2012), and a loss of germ cells has been shown to increase lifespan through the activity of the KRI-1 
adaptor protein (Berman and Kenyon 2006). I tested if this was a possible mechanism by which silencing 
ASI increases lifespan by silencing ASI in the kri-1(ok1251) null background (Figure 2.5 C). In the only  
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Figure 2.5: daf-3, but not kri-1, is required for silencing ASI to extend lifespan. (A) Silencing of ASI failed 
to increase lifespan in the daf-3(mgdf90) null background. (B) Ablation of ASI failed to increase lifespan 
in the daf-3(mgdf90) null background. (C) Silencing of ASI significantly increased lifespan in the kri-
1(ok1251) null background, p=0.01 by log-rank test. 
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lifespan I conducted with this strain, I saw that Tetx significantly increased lifespan in the kri-1(ok1251) 
background. Strangely, the control kri-1(ok1251) single mutants seemed to have a much longer lifespan 
than wild-type animals, a phenotype either not reported in the literature or due to background 
differences in the strains. 
 
The effects of silencing the ASJ neuron pair on lifespan 
Similar to the strain with Tetx in ASI, I created a strain in which the gustatory neuron pair ASJ 
was silenced by expressing Tetx under the ASJ-specific promoter ptrx-1. Previous experiments by Alecdo 
and Kenyon (2004) showed that ablation of ASJ had no effect on wild-type lifespan but completely 
eliminated the lifespan extension caused by ablation of ASI. I saw very different results with silencing of 
ASJ. Silencing of ASJ produced a significant decrease in wild-type lifespan, no effect on the lifespan of 
animals with ablated ASI, and only a small effect on the lifespan of animals with silenced-ASI (Figure 
2.6A).  
 
The strain with the integrated Tetx in ASI construct shows resistance to hsf-1 RNAi  
A reduction in the transcription factor hsf-1 significantly reduces lifespan on its own, and is 
required for many interventions to increase lifespan, including a reduction of IIS (Morley and Morimoto 
2004) and reduction of mTOR signaling (Seo et al. 2013). Therefore I was surprised to find, in each of  
two experiments, that silencing of ASI (but not ablation) significantly increased the lifespan of animals 
grown on hsf-1 RNAi (Figure 2.6 B). I conducted the experiment again on the extrachromosomal strain 
with Tetx in ASI and found in that case the lifespan extension entirely required the function of hsf-1 
(Figure 2.6C), pointing towards an explanation where disruption of function at the genomic site of 
integration or perhaps a mutation linked to the site of integration grants the animals resistance to the 
harmful effects of hsf-1 RNAi.   
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Figure 2.6: Effects of silencing ASJ and hsf-1 RNAi on the lifespan extension caused by silencing of ASI. 
(A) Silencing ASJ reduces the lifespan of wild-type, reduces the lifespan of animals with Silenced ASI to a 
lesser extent, and does not at all reduce the lifespan of animals with ASI ablated 
(p<0.001,p=0.003,p=0.22, respectively by log-rank test before multiple comparisons). (B) Silencing ASI 
(integrated strain) increases the lifespan of animals grown on hsf-1 RNAi, p<0.0001 by log-rank test. (C) 
Silencing ASI (extrachromosomal strain) does not increase the lifespan of animals grown on hsf-1 RNAi.  
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Does tetanus toxin actually block vesicle-based signaling? 
 While Tetx has previously been shown to be functional in C. elegans (Macosko et al. 2009), I 
wanted to see if I could measure its effects on a phenotype other than lifespan. I attempted this in two 
ways: first by comparing the effect of daf-7 mutation, ASI ablation, and silencing of ASI on dauer 
formation at 25 oC, and second by trying to measure the secretion of DAF-26 from ASI in a pgpa-4::daf-
26::RFP strain. In the dauer assay, daf-7 mutants showed a high level of dauers, as previously reported 
(Figure 2.7; Ren et al. 1996). I was surprised to find that ablation of ASI showed fewer dauers than daf-7 
mutants, and animals with silenced-ASI showed no dauer formation whatsoever (Figure 2.7).  
 I attempted to measure the level of secretion from ASI by measuring the intensity of RFP signal 
from coelomocytes in animals with RFP-tagged DAF-26 expressed in ASI. Unfortunately, even after 
multiple attempts and consultation with multiple parties that had conducted the assay, I could not see a 
reliable change in signal between positive and negative controls. 
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Figure 2.7: Effect of silencing and ablating ASI on dauer formation. (A,B) Silencing ASI produces no 
dauers, ablating ASI produces some dauers, and daf-7 mutation produces constitutive dauer formation 
at 25 oC.  
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Discussion: 
 Numerous publications have shown that, across species, the nervous system plays an important 
role in the regulation of lifespan. C. elegans provide an excellent opportunity to explore how single 
neurons can shape the course of health and longevity, and while some neurons have been discovered 
which can affect lifespan and some important pathways by which they mediate this effect have been 
established, the field is still in its infancy. What signals are being detected, how they are being processed 
and measured, and which signaling compounds finally mediate a shift in lifespan are open questions that 
remain to be explored.  
 In this chapter I have shown that disruption of signaling from the gustatory neuron pair ASI 
through either ablation of the neuron or silencing of the neuron with tetanus toxin can extend the 
lifespan of C. elegans. I have further shown that this extension completely requires the function of daf-
3/SMAD and mostly requires the function of daf-16/FOXO, two transcription factors required for 
mutation of daf-7/TGFβ, a secreted factor only expressed in ASI under normal conditions, to extend 
lifespan. While ASI has been shown to affect the germ cell pool size in C. elegans, the increased lifespan 
of silenced-ASI animals in a kri-1(ok1251) null background show that this is unlikely the mechanism by 
which ASI-silencing increases lifespan.  
 Despite the fact that silencing ASI, ablating ASI, and mutation of daf-7/TGFβ all share the 
requirement of daf-3/SMAD to increase lifespan, it is interesting to note that these conditions are not 
identical. In terms of lifespan, daf-16 is entirely required for daf-7 mutation to increase lifespan, but only 
seems partially required for the increase caused by disruption of ASI signaling. Whether this daf-16-
independent lifespan increase is mediated by another secreted molecule from ASI or some effect 
mediated by loss of communication to another neuron remains unknown. The daf-16-independent 
component of the lifespan increase also reinforces the idea that ASI is playing a more complex role than 
simply altering DAF-7 secretion in response to sensory input. Whether this daf-16-independent increase 
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in lifespan is mediated by a chemical signal(s) from ASI or a downstream effect of neuronal 
communication to other neurons remains to be seen.  
daf-7 mutants and silenced-ASI animals show a difference not only in lifespan but also in dauer 
phenotype. At 25oC the vast majority of daf-7 mutant animals formed dauers, whereas only some 
animals with ASI ablated did so and no animals with silenced-ASI were found to do so.  A likely 
explanation for this is that while ASI is the primary neuron responsible for DAF-7 secretion under normal 
conditions, it is not the only neuron capable of doing so (Meissel et al. 2014), and therefore some 
compensatory mechanism to increase DAF-7 secretion in response to specific kinds of reduced-SASI 
signaling may exist to regulate the prevalence of dauers. daf-7-mutant animals, having a defect in the 
gene itself, would not have access to any such compensatory mechanism. Despite ablation and silencing 
of ASI having a similar lifespan phenotype, the difference in dauer phenotype shows that the 
perturbations are physiologically different, perhaps due to some residual, but reduced, chemical 
signaling that exists in ASI expressing Tetx, physiologically important signaling mediated through gap 
junctions, or some unknown response to the presence of the neuron cell body itself. Results from the 
attempted secretion assays would have helped to narrow down the possible explanations, but 
unfortunately they did not render meaningful results. 
 The sod-3 expression data is perhaps the most surprising. A canonical daf-16-target gene, in the 
silenced-ASI condition it shows a robust increase in expression that is independent of daf-16. 
Additionally, the expression pattern of sod-3 itself is interesting. Previous studies have shown that daf-2 
mutant animals have an increase throughout the entire body (Libina et al. 2003), whereas daf-7 animals 
show an increase in expression but only in tissues that are seen to express GFP under normal conditions, 
namely the head, nerve cord, vulva, and tail (Shaw et al. 2007). Despite this similarity, the increase in 
sod-3 expression does not require daf-3, a transcription factor necessary for the daf-7 mutant 
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phenotypes of dauer and lifespan. It is unclear through which mechanism, therefore, silencing ASI is 
increasing sod-3 expression or what that might mean physiologically for the animal. 
 Silencing and ablation show even more dissimilarity in the case of ASJ. Ablation of ASJ shows a 
reduction in the lifespan of ASI-ablated animals, but no effect on wild-type animals, whereas silencing 
ASJ seems to show the opposite effect. This observation is subject to numerous caveats, including the 
fact that I did not measure the lifespan effects of ablating ASJ in my own hands as well as the fact that I 
only conducted the lifespan of silenced-ASJ animals once. However, if this observation proves replicable 
it re-emphasizes the complicated nature of neurons, which are not simple on or off switches but rather 
can increase or decrease the secretion of a variety of signaling molecules in response a diversity of 
inputs. Understanding this complex nature fully will require more precise tools than tetanus toxin or 
whole-cell ablation. 
 While integration can lead to a stable transgenic strain more easily grown in large quantities, my 
experience shows that the integration process comes with caveats. It is important to recover multiple 
integrated strains and test them to find the one with the strongest phenotype so that replicability is not 
lost, especially in the case of a small lifespan increase. It seems somewhat unlikely to me that the 
random site of integration would provide resistance to the highly harmful lifespan effect of knocking 
down hsf-1 with RNAi, but this too could have been avoided if multiple integrants had been recovered. 
Additionally, the mechanism by which this strain is resistant to hsf-1 RNAi remains an interesting and 
unexplored line of inquiry.  
 In conclusion, the silencing of ASI signaling leads to a significant lifespan increase similar to that 
of ablating ASI. This increase seems to be mostly mediated through TGFβ signaling, but it is also partially 
daf-16 dependent. The silenced-ASI strain increases sod-3 in a daf-16-independent manner and shows 
no dauer phenotype. These findings, along with preliminary but similarly surprising findings with the 
silenced-ASJ strain, reveal that the neuronal regulation of lifespan is likely a complex phenotype 
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differentially affected by wide-scale silencing of chemical signaling with tetanus toxin versus ablation of 
the entire neuron.   
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Chapter 3: Communication between the two Fundamental Lifespan Regulators mTOR and Heat Shock 
 
Introduction: 
The health and longevity of an organism depends on robust proteostatic machinery to keep 
proteins functioning properly. One major source of cellular quality control is the heat-shock response 
(HSR). The heat-shock response increases expression of a variety of chaperones in response to many 
stresses, including heat and heavy metals. These so-called heat-shock proteins are coordinately 
regulated by one (in yeast and invertebrates) or multiple (in vertebrates) transcription factors called 
heat-shock factors. In addition, heat-shock factors act under normal conditions to promote longevity 
and developmental growth to adulthood. 
In S. cerevisiae, C. elegans, and Drosophila, a loss of heat-shock factor leads to developmental 
defects at non-stressful temperatures. In yeast, defects in growth caused by lack of HSF activity can be 
rescued by restoring basal expression levels of two heat-shock proteins, Hsp70 and Hsp90, but 
additional Hsf1 target genes are required for resistance to heat stress (Solís et al. 2016). In Drosophila, 
loss of Hsf causes arrest at the first or second larval-instar stage of development, as well as defects in 
oogenesis (Jedlicka et al. 1997). Unlike in yeast, Jedlicka et al. found that this essential developmental 
function in Drosophila was not mediated through canonical heat-shock genes. In C. elegans, HSF-1 is 
needed for progression past the L2-L3 larval stage, and it has been shown to regulate a developmental 
program that is distinct from the heat-shock response by binding to a promoter sequence different from 
the canonical sequence (Li et al. 2016).  
Heat-shock factors are important but not essential for mouse development. Mouse cells lacking 
HSF1 or both HSF1 and HSF2 can be cultured and show normal constitutive transcription of heat-shock 
proteins, although cells without HSF1 are sensitive to heat stress (McMillan et al. 1998; Solís et al. 2016; 
Zhang et al. 2002). In vivo, Hsf1(-/-) mice display additional phenotypes, including growth retardation, 
30 
 
female infertility, prenatal lethality (Xiao et al. 1999, Christians et al. 2000), and neurological defects 
(Santos and Saraiva 2004, Takaki et al. 2006), with the penetrance of prenatal lethality partially 
regulated by the genetic background. Hsf2(-/-) mice also display abnormalities, in both gametogenesis 
and brain structure (Chang et al. 2006). 
While these studies establish that a heat-stress-independent activity of heat-shock factor is 
inextricably tied to development, the genetic pathways and mechanisms by which heat-shock factors 
promote growth and development remain largely unexplored. To address this question in an unbiased 
way, we conducted a genetic screen in C. elegans for suppressor mutations that allow hsf-1(sy441) 
mutant animals to grow to adulthood. The sy441-mutant HSF-1 protein lacks its transactivation domain, 
severely blunting its ability to regulate canonical heat-shock response genes (Hajdu-Cronin et al. 2004). 
These animals grow well at lower temperatures (15-20°C in our hands), but when grown at 
temperatures of 25°C or higher, they display a developmental phenotype similar to that of hsf-1 loss-of-
function mutants, arresting at the L2-L3 stage (Li et al. 2016). 
In this study, we show that mutations in multiple complementation groups allow developing 
sy441 mutants to reach adulthood. These mutations dramatically postpone, but do not eliminate, 
growth arrest within the strain’s lineage, as the rescued adults produce progeny that fail to progress 
through development. We show that one of these mutations is a putative null allele of rsks-1/S6Kinase, 
a translational activator regulated by the mechanistic Target of Rapamycin mTOR. We find that 
knockdown of various mTOR-pathway components can also rescue the phenotype. Unexpectedly, we 
find no evidence that phenotypic rescue is mediated by inhibition of translation. Nor does rescue appear 
to be due to the activation of other stress responses such as the ER unfolded-protein response or the 
mitochondrial unfolded-protein response; nor is it due to the activation of various stress-resistance 
pathways known to extend adult lifespan.  
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We find that the rescue mediated by loss of S6 Kinase is dependent upon residual activity of the 
mutant HSF-1(sy441) protein, and that transgenically-increased expression of the hsf-1(sy441) allele is 
sufficient on its own to rescue development. However, we see no evidence that the S6 kinase mutation 
increases expression of hsf-1 nor any of a variety of target genes we examined. We conclude that loss of 
S6 kinase could potentially elevate other targets of hsf-1 or, alternatively, provide other factors that 
allow low levels of HSF-1 activity to sustain growth to adulthood. 
 
Materials and Methods: 
C. elegans strains: 
Wild-type (N2) 
VB654: rsks-1(sv31); svEx136[unc-36(+) rsks-1(+) sur-5::gfp] 
  AGD794: hsf-1(sy441); uthIs225[sur-5p::hsf-1(sy441); myo2p::tdTomato]  
CF3951: hsf-1(sy441) 
CF4522: hsf-1(sy441) with an unidentified suppressor mutation 
CF4523: hsf-1(sy441) with an unidentified suppressor mutation 
CF4524: hsf-1(sy441) with an unidentified suppressor mutation 
CF4525: hsf-1(sy441); rsks-1(mu482) 
CF4526: hsf-1(sy441) with an unidentified suppressor mutation 
CF4540: hsf-1(sy441); rsks-1(sv31) 
CF4542: hsf-1(sy441); rsks-1(mu482); svEx136[unc-36(+) rsks-1(+) sur-5::gfp] 
CF4543: hsf-1(sy441); T24F1.4(tm5213) 
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Development assay: 
            Arrested L1 larvae were spotted onto plates preheated to 25.8°C. After spotting, plates were 
placed back at 25.8°C in an open Tupperware container for one hour to re-equilibrate temperature. 
After one hour, the container was closed (except for one corner) to prevent drying for four days. Each 
condition utilized four plates containing roughly 25 animals each. After 4 days, conditions were blinded 
and scored on a qualitative five-point scale for developmental stage. Animals with a score of three had 
passed the point of vulval eversion (transition to adulthood) but had not yet produced any eggs. 
Therefore, animals with a score of three or higher were classified as adults in the figures and tables 
shown here.  
 
EMS Mutagenesis and screening: 
Mutant hsf-1(sy441) worms grown at 20oC on OP50 were bleach-prepped, and the eggs were 
incubated overnight in M9. The next day, a total of 10,000 L1 larvae were divided among four 10 cm 
plates containing OP50 (~2500/plate) and incubated at 20oC. Once this P0 population reached early L4, 
the worms were collected from the plates, washed 3 times, and re-suspended in 15mL of M9 buffer. In a 
separate 50mL conical tube, 100µL of EMS (Sigma #M-0880) was mixed into 5mL of M9. The worm 
suspension was then added to this new conical tube containing EMS, the top was parafilmed, and the 
tube was placed in a rotator at 20oC for 4 hours. The final concentration of EMS under these conditions 
was ~50mM, for an expected mutation rate of 5x10-4 mutations/gene/gamete (Brenner, 1974). Next, the 
worms were pelleted, the supernatant was removed, and the worms were washed thrice with 15mL of 
M9. Lastly, the worm pellet was split equally among four 10cm plates containing OP50, and recovered at 
20oC for 24 hours. 
         At the end of this recovery period, the P0 animals were collected from the plates and bleached 
using standard protocol. Assuming 5 viable eggs were obtained per P0, this yielded a total of ~50,000 
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F1’s, representing 50x genomic coverage. These eggs were plated evenly onto 20 separate 10cm plates 
containing OP50 (2500/plate), and grown to adulthood at 20oC. The gravid populations on each of these 
20 plates were then collected individually and bleached, and each resulting batch of F2 eggs was plated 
onto its own 15cm plate containing OP50 (25,000/plate). The F2 worms were then grown at 25oC. On day 
5, the plates were screened for any worms that had developed beyond the L3 arrest phase, and these 
candidates were collected onto individual 3cm OP50 plates and recovered at 20oC. 
 
Validation and Phenotypic Analysis of Screen Hits: 
          All candidates recovered from the screen were validated by determining whether the 
suppression-of-hsf-1-arrest phenotype bred true to the next generation. Those that failed this test were 
discarded. The validated lines were then genotyped for reversal of the hsf-1(sy441) point mutation, with 
intent to discard true genetic revertants.  
In order to narrow down the 17 remaining mutant lines, we further characterized them for 
penetrance and expressivity. First, we measured the percentage of suppression-of-hsf-1-arrest that each 
line displayed. This was done by picking 50 eggs onto a 3cm OP50 plate, incubating for 4 days at 25oC, 
and then counting the number of worms that developed past L3 arrest. Investigation was continued only 
for lines with 50% or higher population rescue. Next, we determined the furthest developmental stage 
each line could achieve at 25oC, using the same experimental set-up just described, and only pursued 
those that could produce gravid adults.          
 
Genetic Characterization of Screen Hits: 
We characterized the allelic nature of the 9 remaining lines. Males were generated for each, as 
well as for hsf-1(sy441) single mutants, and reciprocal crosses were carried out to identify any dominant 
or sex-specific mutations. Given that all suppressors were found to be recessive, the males generated 
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above were then used to perform complementation assays. To ensure independence, all lines isolated 
from the same plate (of the original 20) were interrogated with reciprocal crosses, looking for 
heterozygous progeny that maintained the suppression-of-hsf-1-arrest phenotype. Second, reciprocal 
complementation crosses were carried out between all remaining lines (across the original 20 
populations), with the intent to again keep only one from each complementation group. This yielded a 
set of five lines with unique, recessive, and penetrant mutations that allowed hsf-1(sy441) worms to 
reach gravid adulthood at 25oC. Four of these five strains exhibited extended lifespan at 20oC, but this 
phenotype was lost upon backcrossing. 
 
Identification of candidate genes: 
These five suppressor strains were backcrossed to the control hsf-1(sy441) strain a total of six 
times before genomic sequencing. The suppressor strains were then backcrossed a total of nine times 
before use in all other experiments.  
Genomic DNA from each mutant strain was isolated from roughly 300µl of pelleted worms from 
a mixed population. DNA was sheared using the Covaris M220 sonicator to an average length of 350 
base pairs. After shearing, DNA was quantified using the Qubit dsDNA high sensitivity assay kit. DNA 
libraries were prepared from genomic DNA utilizing the Bioo Scientific NEXTflex Rapid DNA-Seq Library 
Prep Kit. Library quality was assessed utilizing the Agilent high-sensitivity DNA analysis kit. Libraries were 
sequenced by the UCSF Institute for Human Genetics Core Facility according to the manufacturer's 
protocol using an Illumina HiSeq 2500.  
Genomic information from the Human Genetics Core Facility was analyzed using the Galaxy 
platform through Amazon Web Services. Genes with high-quality protein-coding point mutations were 
then examined for effects on the development arrest phenotype.  
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Lifespan Analysis: 
Life span analysis was performed at 20°C as described previously (Apfeld and Kenyon 1998). 
Animals were grown on OP50 E. coli and transferred to fresh plates on the first day of adulthood (“day 
1”) and every 2 days thereafter. Every two days, starting on day 1, animals were scored. Animals that 
moved were scored as alive, animals that did not move, even after being prodded with a platinum wire, 
were scored as dead, and animals that could not be found or displayed phenotypes such rupturing or 
bagging were censored. 
 
Translation Inhibiting Drugs: 
Salubrinal (SML0951) and homoharringtonine (SML1091) were purchased from Sigma-Aldrich. 
Cycloheximide (#94271) was purchased from VWR Life Sciences. Drugs were diluted and spotted on 
plates with bacteria to a final DMSO concentration of 0.19% (unless otherwise noted) and allowed to 
diffuse into the agar for one day before animals were plated for development experiments. 
 
Real-time qPCR: 
RNA extraction, cDNA preparation, and real-time qPCR were performed as described previously 
(Van Gilst et al. 2005) from 3 biological replicates of each condition, with at least 500 animals included in 
each condition. For larval experiments, animals were grown from arrested L1 larvae at 25.8°C until >50% 
of the population had grown to the L1 lethargus stage between the L1 and L2 larval stages 
(approximately 13 hours for wild-type background and approximately 16 hours for hsf-1(sy441) 
background) before being washed and flash-frozen for RNA extraction. For heat-shock experiments, 
animals were grown from arrested L1 larvae at 20°C until >50% of the population had reached young 
adulthood, after which the animals were separated into heat-shock conditions, which were placed at 
30°C, and non-heat-shock conditions, which were placed at 20°C, for one hour before being washed and 
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flash-frozen for RNA extraction. Data were standardized to three control primers: tba-1, cdc-42, and 
pmp-3. For rps-6 dilution experiments, data were standardized to tba-1 and cdc-42 only. Primer 
sequences are listed in table 3.3. 
 
RNAi:  
HT-115 RNAi bacteria were obtained from existing Ahringer and Vidal libraries. The control for 
all RNAi experiments was L4440 vector. For each experiment, single colonies were grown overnight at 
37°C in 3 mL LB with 100µg/mL carbenicillin and 10µg/mL tetracycline. The next day, the resulting 
stationary-phase cultures were diluted tenfold with LB containing 100µg/mL carbenicillin and grown for 
two hours at 37°C. 1M IPTG was then added to the culture to reach a final concentration of 2mM, after 
which 100µL of the resulting culture were spotted onto NGM plates. The bacteria were grown on these 
plates overnight at 30°C. Animals were placed on plates the following day in all experiments except 
those involving a drug condition, in which case drugs were added and left to diffuse into the plate for an 
additional day before the addition of experimental and control animals.  
 
Size Measurement: 
 Arrested L1 larvae were spotted onto plates preheated to 20°C (for young-adult experiments) or 
25.8°C (for larval experiments). For young-adult experiments, animals were grown for three days at 
20°C, and for larval experiments, animals were grown until L1-L2 lethargus at 25.8°C. Animals were then 
washed off plates, immobilized in 10mM levamisole, and imaged at 80x magnification. Animal size was 
then quantified in ImageJ by measuring the area inside a polygon drawn around each animal.  
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Statistical Analyses: 
On all dot plots, bars represent the mean, and error bars represent the SEM. For developmental 
assays of multiple genes in parallel, significance was measured across three independent experiments 
using Cochran-Mantel-Haenszel tests with Bonferroni corrections unless otherwise noted. For lifespan 
assays, log-rank tests with Bonferroni corrections were used. For RT-qPCR experiments and animal size 
experiments, one-way ANOVAs with Tukey post tests were used on three biological replicates.  
 
Results: 
A genetic screen identifies mutations that rescue the hsf-1(sy441) developmental arrest 
To investigate how hsf-1 regulates development, we conducted an unbiased forward 
mutagenesis screen in C. elegans to rescue the growth-arrest phenotype displayed by hsf-1(sy441) 
mutants grown at 25°C. Following EMS mutagenesis (Brenner 1973), we recovered seventeen 
independent mutants that, when shifted from 20°C to 25.8°C at the mid-L4 (final) larval stage, produced 
progeny that grew to adulthood. We picked five strains (see methods) to backcross and sequence to 
discover candidate genes. hsf-1(sy441) mutants carrying the suppressors reached adulthood exhibiting 
apparently-normal anatomy, but they displayed a reduced body size and could not be cultivated past a 
single generation at 25.8°C (Figure 3.1A, B). The progeny of some strains grown at 25.8°C produced eggs 
that did not hatch, whereas others produced progeny that arrested at L1. If adult animals were shifted 
back to 20°C, they produced offspring which developed normally. 
When parents were shifted to 25.8°C at the L4 stage, 100% of hsf-1(sy441) progeny without 
suppressor mutations arrested at the L1-L3 stage, whereas 100% of progeny homozygous for the five 
suppressor mutations reached adulthood. If instead eggs were bleach-extracted from the gonads of the 
parental generation at 20°C, allowed to hatch into minimal medium (causing L1 developmental arrest), 
and then placed on 25.8°C plates, a small percentage of hsf-1(sy441) single mutant-animals could reach   
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Figure 3.1: Mutants discovered in a mutagenesis screen for rescue of the developmental arrest of hsf-
1(sy441) mutants. (A) Appearance of wild-type, hsf-1(sy441), and multiple suppressor strains after 4 
days at 25.8°C from arrested L1 larvae cultured at 20°C, imaged at 100x magnification. Strains CF4522, 
CF4523, CF4524 and CF4526 contain additional suppressors from the screen, but were not analyzed 
further in this study. (B) Appearance of wild-type, hsf-1(sy441), and CF4525 suppressor strain grown at 
25.8°C to various timepoints from arrested L1 larvae cultured at 20°C, imaged at 600x magnification.   
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early adulthood but rarely produced eggs, while still 100% of progeny homozygous for the suppressor 
mutations reached adulthood. In order to detect subtle shifts in the percentage of animals that reached 
adulthood, all of the assays described here utilized arrested L1 larvae hatched at 20°C and then shifted 
to the higher temperature.  
Because our suppressor mutations rescued the developmental growth-arrest phenotype of hsf-
1(sy441) animals, we tested whether they could also rescue another well-documented hsf-1(sy441) 
phenotype, shortened adult lifespan (Garigan et al. 2002; Hajdu-Cronint et al 2004). None of the 
mutants extended the shortened lifespan that hsf-1(sy441) mutant-animals exhibit at the temperatures 
permissive for growth (Figure 3.2). We also tested whether the suppressor strains affected resistance to 
heat stress. To our surprise, we found that our hsf-1(sy441) background was more heat resistant than 
wild-type, but this seemed unaffected by most of the suppressor mutations. CF4524 was a lone 
exception and showed more thermosensitivity(Figure 3.3).  
 
Loss of the gene rsks-1 rescues the hsf-1(sy441) developmental arrest 
Genomic sequencing revealed that one of the suppressor strains (CF4525) contained a 
premature stop codon in the gene rsks-1 at the 295th base pair, rsks-1(mu482). The rsks-1 gene encodes 
C. elegans’ ribosomal S6 Kinase ortholog, which promotes normal levels of translation. We determined 
that this mutation was the causative factor for the developmental rescue in two ways: first, we 
confirmed the developmental rescue with a previously-isolated null allele, rsks-1(sv31), and with RNAi-
mediated knockdown of rsks-1 (Figure 3.4A). Second, we showed that transgenic re-expression of rsks-1 
in the suppressor strain blocked the rescue phenotype (Figure 3.4B, C). While there was variation in the 
baseline percentage of hsf-1(sy441) animals that reached adulthood (Tables 3.1-3.2), this variation did 
not obfuscate the rescue phenotype of rsks-1 RNAi. In 44 out of 46 trials, we saw a significant difference  
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Figure 3.2: Strains carrying suppressors of the developmental arrest of hsf-1(sy441) mutants do not 
extend lifespan, either without (A) or with (B) the addition of 50μM FUDR to prevent progeny 
production. Bottom graphs display the same data as the graphs above them, showing only a subset of 
strains for clarity. 
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Figure 3.3: Thermotolerance of hsf-1(sy441) and suppressor strains. (A) Average survival after 4 hours in 
a 35°C incubator, data points are percent alive on six plates of approximately seventeen animals per 
condition. (B) Average survival after 4.5 hours a 35°C incubator, data points are percent alive on six 
plates of approximately seventeen animals per condition. (C,D) Average survival over time at 35°C. Data 
points are the average percent alive of three plates with approximately 40 animals scored quickly at 
room temperature before being placed back at 35°C.
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Figure 3.4: Loss of rsks-1/S6 kinase or reduction of mTOR function was sufficient to rescue the 
developmental arrest of hsf-1(sy441). (A) Loss of rsks-1 rescued the developmental arrest of hsf-
1(sy441), ***p < 0.001 compared to hsf-1(sy441) using the CMH test with three replicates. (B,C) 
Transgenic overexpression of rsks-1::GFP in hsf-1(sy441); rsks-1(mu482) double mutants suppressed the 
rescue. All animals are hsf-1(sy441); rsks-1(mu482) double mutants with the stochastically-inherited 
transgene svEx136[unc[36(+) rsks-1(+) sur-5::gfp]. Strain identity was blinded and development was 
scored, and then groups were categorized based on whether GFP was visible, ***p<0.001 compared to 
animals without GFP using the CMH test with three experiments; animals were imaged at 100x 
magnification. (D) RNAi knockdown of genes in the mTOR pathway also rescued the developmental 
arrest of hsf-1(sy441), *p<0.05, ***P<0.001 compared to hsf-1(sy441) using the CMH test with three 
replicates (four for daf-15). 
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in the percentage of hsf-1(sy441) animals that developed to adulthood between animals grown on 
vector-only control RNAi bacteria and those grown on rsks-1 RNAi bacteria (Figure 3.5). 
 
Reduction in mTOR-pathway function also rescues the hsf-1(sy441) developmental arrest 
What is the mechanism by which rsks-1 loss influences hsf-1 mutants? S6 kinase is a key target 
of mTOR kinase. To determine if the developmental rescue phenotype could be produced by a reduction 
in mTOR activity more broadly, we used RNAi to knock down daf-15/RAPTOR, a component of the 
mTORC1 complex, as well as ragc-1/RAG GTPase, a positive regulator of mTORC1 (Fukuyama et al. 2012; 
Jia et al. 2004). Reduced expression of both of these genes significantly rescued the hsf-1(sy441) 
developmental arrest (Figure 3.3D), albeit to a lower degree than did RNAi knockdown of rsks-1.  
  
rsks-1(-)-mediated hsf-1(sy441) rescue was not mimicked by a reduction in translation 
Loss of rsks-1 causes a reduction in translation (Hansen et al. 2006). One possible explanation 
for the mechanism of developmental rescue conferred by rsks-1 mutation is that hsf-1(sy441) animals, 
predicted to have reduced proteostatic capability, are overburdened by the amount of protein being 
translated during development at 25°C, and the reduced rate of translation incurred by mutating rsks-1 
reduces that burden to a manageable level in hsf-1(sy441) worms. To investigate this hypothesis, we 
reduced translation in other ways, by treatment with several chemical inhibitors of translation and via 
various RNAi treatments. If our hypothesis were correct, one would expect the following: at high 
concentrations these treatments would be lethal and at low concentrations they would have no effect, 
but at some range of intermediate concentrations they would lower the translation rate to a level 
permissible for developmental rescue.  
We first used RNAi to knockdown rps-6, encoding a small ribosomal protein that is 
phosphorylated by S6 kinase. Because a reduction in translation is known to result in reduced body size  
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Figure 3.5: The percentage of hsf-1(sy441) animals which reach adulthood at 25.5°C is variable, but rsks-
1 knockdown robustly increases this percentage. (A) rsks-1 RNAi significantly increases the percentage of 
hsf-1(sy441) animals which develop to adulthood in 44 out of 46 trials, data points from the same 
experiment are connected by a line. (B) Box and whisker plots of the percentage of hsf-1(sy441) animals 
which developed to adulthood across 46 replicates. 
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(Pan et al. 2007), we assessed the efficacy of translational knockdown indirectly by measuring 
the size of the young-adult animals grown at 20°C on rps-6 RNAi diluted with vector control to achieve 
multiple levels of knockdown (Figure 3.6A). At concentrations that significantly reduced animal size close 
to that of rsks-1(mu482) mutants, we found that rps-6 RNAi reduced the number of hsf-1(sy441) animals 
that reached adulthood (Figure 3.6B-C), showing that a reduction in translation may actually be harmful 
to hsf-1(sy441) development. To see whether rps-6 RNAi treatment on its own was perhaps stressful or 
toxic to the animals, we measured expression of levels of canonical genes from the ER unfolded-protein 
response (UPR), mito-UPR, or HSR pathways using RT-qPCR, and found that none were significantly 
altered (Figure 3.6D, Figure 3.7A). This was despite seeing a significant, if smaller, effect of rps-6 
inhibition on animal size at this time point (Figure 3.6B).  
We also tested the effects of other translation-inhibiting conditions, including RNAi of ifg-1, a 
gene which promotes translation additively with S6 kinase (Pan et al. 2007), salubrinal, a chemical 
inhibitor or translation initiation, and homoharringtonine, a chemical inhibitor of elongation (Figure 
3.7C-F, Table 3.1).  Similar to knockdown of rps-6, treatment with homoharringtonine caused a 
reduction in the percent of animals that developed to adulthood at concentrations that also significantly 
reduced animal size.  Animals treated with higher concentrations of salubrinal and ifg-1 RNAi showed a 
similar reduction.  Only hsf-1(sy441) animals grown on 45nM salubrinal showed a marginally-significant 
increase in development to adulthood. Thus, while multiple distinct methods for reducing translation 
could cause reductions in animal size, no translation-inhibiting conditions mimicked the rescuing effect 
of rsks-1 inactivation in terms of either penetrance or expressivity on development of hsf-1(sy441) 
animals. Together, these data suggest that reduced translation alone cannot explain the rsks-1(mu482) 
mutation’s rescue of hsf-1(sy441)’s development. 
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Figure 3.6: The ability of rsks-1(-) to rescue of the development of hsf-1(sy441) mutants is not explained 
by a reduction in translation. (A) rps-6 RNAi reduces the size of hsf-1(sy441) young-adult animals grown 
at 20°C. Serial 2-fold dilution of rps-6 RNAi produced incrementally smaller effects (50% denotes 1:1 rps-
6:vector-control RNAi-bacteria). (B) Dilutions of rps-6 RNAi-bacteria with vector-control RNAi-bacteria 
that show size reduction similar to rsks-1(mu482) mutants significantly reduce the percent of hsf-
1(sy441) animals which develop to adulthood at 25.8°C (50% denotes 1:1 rps-6:vector-control RNAi), 
***p<0.001 compared to control hsf-1(sy441) by CMH test with three replicates. (C) None of multiple 
dilutions of rps-6 RNAi-bacteria with vector-control RNAi-bacteria rescued developmental arrest at 
25.8°C (50% denotes 1:1 rps-6:vector-control RNAi), ***p<0.001 compared to control hsf-1(sy441) by 
CMH test with three replicates. (D) Concentrations of rps-6 RNAi-bacteria that reduce baseline 
development to adulthood of hsf-1(sy441) animals do not activate stress-response ER-UPR, mito-UPR, or 
HSR pathways in animals grown at 25.8°C and harvested at the L1-L2 lethargus stage, by one-way 
ANOVA with Tukey post-test on three biological replicates.  
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Figure 3.7: The ability of rsks-1(-) to rescue of the development of hsf-1(sy441) mutants is not explained 
by a reduction in translation. (A) rps-6 RNAi inhibition does not activate stress-response ER-UPR, Mito-
UPR, or HSR pathways in wild-type animals grown at 25.8°C and harvested at the L1-L2 lethargus stage 
(50% denotes 1:1 rps-6:vector-control RNAi-bacteria). (B) rps-6 RNAi inhibition significantly reduces the 
size of animals grown at 25.8°C at the L1-L2 lethargus stage (in 2/3 replicates, ***p<0.001 by Student’s 
t-test). (C) Two concentrations of the translation initiation inhibitor salubrinal showed a small amount of 
rescue near p=0.05 level of significance, ***p<0.001 compared to control hsf-1(sy441) by CMH test with 
three replicates. (D) None of multiple concentrations of ifg-1 RNAi rescued developmental arrest (1% 
denotes 1:99 ifg-1:vector-control RNAi-bacteria), ***p<0.001 compared to control hsf-1(sy441) by CMH 
test with three replicates. (E) 185µM translation elongation inhibitor homoharringtonine significantly 
reduces the size of hsf-1(sy441) young-adult animals grown at 20°C in 2/3 replicates, ***p<0.001 
compared to control by one-way ANOVA with Tukey post-test. (F) 185µM translation elongation 
inhibitor homoharringtonine significantly reduces the percentage of hsf-1(sy441) animals which develop 
to adulthood, ***p<0.001 compared to control by CMH test with three replicates. 
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rsks-1(-) mutants do not activate canonical unfolded-protein response pathways 
Because we could not attribute the rescuing effects of rsks-1 mutation to a simple lowering of 
the translational burden, we hypothesized that it might be increasing the animal’s capability to manage 
proteotoxic stress through non-heat-shock response pathways such as the mitochondrial or ER UPR  
pathways. Like the heat-shock response, these pathways upregulate the expression of protein 
chaperones such as BIP/HSP-70 which facilitate protein folding (Shen et al. 2001).   
The development of hsf-1(sy441); rsks-1(mu482) double mutants was partially inhibited by 
knockdown of the ER-UPR pathway gene xbp-1 (Figure 3.8A), an intervention that has no effect on wild 
type, showing that the animals are sensitive to disruption of additional proteostatic systems beyond the 
heat-shock response. This suggests the possibility that rsks-1 loss up-regulates xbp-1 transcriptional-
target genes, such as hsp-4 (the C. elegans BIP ortholog). However, when assayed using RT-qPCR, hsp-4 
did not appear to be upregulated by loss of rsks-1 in hsf-1(sy441) mutants (Figure 3.8B). Likewise, RT-
qPCR of the mitochondrial-UPR target gene hsp-6 revealed that the mitochondrial-UPR was not 
upregulated. These findings suggest that an increase in UPR function is not the mechanism by which 
rsks-1 loss rescues development. 
 
The developmental rescue of hsf-1(sy441) mutants is mTOR-specific but does not act through canonical 
lifespan pathways that interact with mTOR 
mTOR and heat-shock factor are intimately tied to lifespan regulation and stress resistance. We 
wondered whether activating other pathways known to increase lifespan and proteostasis could also 
rescue its development. Both daf-2 (insulin/IGF-1 receptor) and cco-1/cox-5B (mitochondrial electron 
transport gene) RNAi extend lifespan (Dillin et al. 2002; Kenyon et al. 1993), but neither rescued the 
block in hsf-1(sy441) development (Figure 3.8C). In fact, daf-2 RNAi seemed to have a negative effect on 
development. To further investigate, we used RNAi to inhibit the transcription factors daf-16, pha-4 and  
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Figure 3.8: Stress-responses in hsf-1(sy441) animals carrying the rsks-1(mu482) suppressor. (A) hsf-
1(sy441); rsks-1(mu482) double mutants are more sensitive to RNAi of xbp-1, an activator of the ER UPR, 
than are wild-type animals, ***p<0.001 using CMH test with three replicates. (B) Canonical ER UPR and 
mitochondrial UPR chaperones were not upregulated in hsf-1(sy441); rsks-1(mu482) double mutants, 
using one-way ANOVA with Tukey post-test on three biological replicates. (C) Inhibition of the daf-2 
insulin/IGF-1 receptor or the mitochondrial electron transport chain, which extend the lifespan of wild 
type, failed to rescue the developmental arrest of hsf-1(sy441) mutants, ***p<0.001 using CMH test 
with three replicates. (D) Transcription factors required for mTOR reduction-of-function to extend 
lifespan are not required for rsks-1 mutation to rescue hsf-1(sy441) developmental arrest, using CMH 
test with three replicates.                                   
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skn-1. Each of these genes promotes C. elegans’ stress resistance and lifespan extension in mTOR 
reduction-of-function and/or other long-lived mutants (Robida-Stubbs et al. 2012; Seo et al. 2013; 
Sheaffer et al. 2008), but none blocked the ability of rsks-1 loss to rescue the hsf-1(sy441) 
developmental arrest (Figure 3.8D). We then tested a subset of genes in the published literature that  
have been shown to be a part of the genetic networks associated with rsks-1 or hsf-1, including those 
from microarray datasets (Baird et al. 2014; Chen et al. 2013; Magnuson et al. 2012). Of the 65 
additional genes tested, we saw no evidence of RNAi knockdown either rescuing the development of 
hsf-1(sy441) mutants or having a more severe reduction-of-development effect on hsf-1(sy441); rsks-
1(mu482) double mutants vs. wild-type (Table 3.2).  
 
Developmental rescue requires residual hsf-1 function but does not act through canonical heat-shock-
regulated genes 
Despite the lack of its transactivation domain, the fact that the hsf-1(sy441) allele does not 
cause arrest at 20°C, as the null mutation does (Li et al. 2016), shows that the HSF-1(sy441) mutant 
protein retains some functionality. To test whether endogenous levels of the mutant protein are 
required for rsks-1 null mutations to rescue development at 25.8°C, we knocked down hsf-1 using RNAi 
in the hsf-1(sy441); rsks-1(mu482) double mutant. RNAi knockdown of residual HSF-1(sy441) function 
blocked the rsks-1 rescue phenotype (Figure 3.9A). In addition, we found that transgenically increasing 
the hsf-1(sy441) gene dosage was sufficient to rescue the developmental arrest of hsf-1(sy441) mutants 
(Figure 3.9B).  However, despite the fact that residual levels of HSF-1(sy441) are necessary for 
developmental rescue and overexpression of HSF-1(sy441) can be sufficient for developmental rescue, 
we saw no evidence through RT-qPCR that rsks-1 mutation elevated the expression levels of the hsf-1 
gene nor genes known to be regulated by HSF-1 in heat-shock or developmental contexts (Figure 3.9C) 
(Li et al. 2016). Thus, the hypothesis that, directly or indirectly, loss of S6 kinase promotes growth to  
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Figure 3.9: hsf-1(sy441) activity is necessary and can be sufficient to rescue developmental arrest, but 
rsks-1(mu482) does not appear to affect expression of hsf-1 or its canonical targets. (A) hsf-1 RNAi 
treatment prevented two rsks-1/S6 kinase null mutations from rescuing the developmental arrest of hsf-
1(sy441) mutants, ***p<0.001 using the CMH test with three replicates. (B) Overexpression of the hsf-
1(sy441) allele rescued the developmental arrest of hsf-1(sy441) mutants, ***p<0.001 using the CMH 
test with four replicates. (C) Expression levels of canonical heat-shock genes and developmentally-
regulated hsf-1-response genes are unaffected by the rsks-1(mu482) mutation, as measured by RT-
qPCR, *p<0.05 **p<0.01 ***p<0.001 by one-way ANOVA with Tukey multiple comparison post-test 
measured for each gene independently with three biological replicates. 
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adulthood by enhancing the effectiveness of HSF-1(sy441) remains an attractive, though unproven, 
model. 
Three findings from our RT-qPCR experiments were surprising. First, we found that hsf-1(sy441) 
animals exhibited a higher level of hsf-1 expression compared to wildtype. Second, we found that rsks-1  
mutation did not increase expression of hsp-16.2 or the hsp-70 gene F44E5.4, in contrast to a previous 
report (Seo et al. 2013). Third, one might suspect hsp-16.2 and hsp-70 (F44E5.4) expression levels to be 
higher in wild type than in hsf-1(sy441) mutants because 25.8°C is higher than the ambient temperature 
for C. elegans, but this was not the case. To more closely replicate previously published experiments, we 
conducted new RT-qPCR experiments on young-adult animals which were grown at 20°C and then heat 
shocked at 30°C or left at ambient temperature for one hour. Under these conditions, as shown 
previously, the increase in hsp-16.2 expression upon heat shock was severely blunted in the hsf-1(sy441) 
background (Figure 3.10A). Curiously, hsp-70 (F44E5.4) expression was unaffected (Figure 3.10B), 
suggesting that the sy441 allele affects only a subset of heat-shock target genes. Contrary to Seo et al., 
we did not observe an increase in the expression of hsp-16.2 or hsp-70 (F44E5.4) in rsks-1 mutant 
animals compared to wild-type (Figure 3.9C), but we did see a possible increase in hsp-70 (F44E5.4) 
expression after heat shock in rsks-1 mutant animals. This suggests to us that loss of rsks-1 can affect the 
regulation of heat-shock genes, but the mechanism may be complicated by factors such as genetic 
background or differences between rsks-1 mutant alleles. Finally, we found that the increase in hsf-1 
expression seen in hsf-1(sy441) mutant larvae was no longer significant in adulthood (Figure 3.10D). 
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Figure 3.10: Effect of genetic background and 30°C heat shock on change in expression of hsf-1, hsp-
16.2, and hsp-70. (A) Heat shock increases expression of hsp-16.2 significantly more in wild-type young-
adult animals compared to hsf-1(sy441) mutant animals, #p>0.05, ***p<0.001 by one-way ANOVA with 
Tukey post-test on three biological replicates. (B) Heat shock increases the expression of hsp-70(f44e5.5) 
equally in wild-type and hsf-1(sy441) animals, and rsks-1(mu482) mutation may increase the expression 
of hsp-70(f44e5.5) after heat shock, #p>0.05, *p<0.05, ***p<0.001 by one-way ANOVA with Tukey post-
test on three biological replicates. (C) hsf-1(sy441) young-adult animals have significantly reduced hsp-
16.2 expression but not hsp-70(f44e5.5) expression compared to wild-type at 20°C, #p>0.05, **p<0.01, 
by one-way ANOVA with Tukey post-test on three biological replicates. (D) Young-adult hsf-1(sy441) 
animals grown at 20°C show a trend, but no significant change in hsf-1 expression levels, unlike that 
seen in animals grown at 25.8°C and harvested at L1-L2 lethargus, #p>0.05, by one-way ANOVA with 
Tukey post-test on three biological replicates. 
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Discussion: 
            hsf-1 and its orthologs have been studied extensively in the contexts of stress, aging, and human 
pathologies such as cancer and neurodegenerative diseases (Li et al. 2017). Despite characterization of 
the requirement for a functioning heat-shock factor during development, the specific molecular roles it 
plays in development remain largely unknown. In this paper we show that the mTOR pathway, and more 
specifically the downstream mTOR target ribosomal S6 kinase, acts to truncate development in hsf-
1(sy441) reduction-of-function mutants. 
Interestingly, lifespan extension caused by inhibiting S6-kinase or mTOR activity is known to be 
blocked by the hsf-1(sy441) mutation (Seo et al. 2013). Consistent with this finding, our S6-kinase 
suppressor mutation failed to extend the lifespan of hsf-1(sy441) mutants. While this finding shows that 
HSF-1 is required for rsks-1 loss to extend lifespan, here we find another reciprocal relationship; namely, 
that rsks-1 loss can rescue the developmental arrest caused by reduction of HSF-1 function. In one case, 
low levels of S6K cause endogenous levels of HSF-1 to extend lifespan, whereas in the other case, low 
levels of HSF-1 cause endogenous levels of S6K to arrest development. The details of these reciprocal 
interactions remain elusive; nevertheless, our findings reveal a recurring, but potentially complex, 
relationship between these two important regulators of development, stress resistance, and lifespan. 
 It is interesting to note that when hsf-1(sy441) homozygotes are shifted to 25°C at the L4 larval 
stage, they lay eggs that hatch but fail to reach adulthood. However, when L1 larvae are starvation-
arrested at 20°C and then fed and shifted to 25.8°C, some of those larvae reach adulthood. In other 
words, the general “arrest point” in the life cycle is different under these two conditions. This finding 
indicates that hsf-1 loss does not cause a growth blockade at one specific point in the life cycle. Instead, 
this finding suggests the model that loss of HSF-1 function impacts a time-dependent accumulation of 
proteostatic damage rather than a specific developmental requirement. The opposite situation occurs in 
Drosophila, where HSF-1 activity is dispensable specifically after passing the first two larval stages 
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(Jedlicka et al. 1997). Because no hsf-1(sy441); rsks-1(mu482) double-mutant animals arrest in the first 
generation but do produce progeny which then arrest, we hypothesize that loss of rsks-1 does not 
bypass HSF-1 function but rather delays or reduces the damage caused by the reduction of HSF-1 
function. 
            It is surprising that we were unable to phenocopy the effects of rsks-1 mutation through any 
mechanism other than mTOR knockdown, a condition predicted to reduce rsks-1 activity. While we 
cannot know for certain whether a very specific amount of translation inhibition could rescue the 
developmental arrest, we have established that multiple methods of reducing translation at multiple 
concentrations are insufficient to rescue development, and indeed at levels of translation inhibition that 
significantly reduce animal size, we tended to find a harmful effect on development. If reduced 
translation were the mechanism of growth arrest suppression, then the situation we found in this study 
would contrast dramatically with the effects that a similar scan of translation-RNAi knockdowns 
produced on another phenotype, lifespan extension. In that case, a wide variety of RNAi knockdowns 
scored positively, even without careful dose-response analysis (Hansen et al. 2006).  
Another potential way that translation could be involved in this phenotype is if inhibiting S6K 
fails to inhibit, or even promotes, the translation of a specific subset of genes. Many stress responses, 
such as the heat-shock response and integrated stress response, activate a subset of genes while 
inhibiting translation generally. If S6K inhibition causes a similar effect, then chemical or RNAi-mediated 
inhibition of translation alone, without activation of specific targets, would not be enough to rescue 
development.               
Other than the small inhibition of rescue caused by xbp-1 knockdown and the rescue caused by 
knockdown of daf-15 and ragc-1, we did not identify other genes known to interact with rsks-1 that are 
related to this phenotype. The finding that daf-2 and cco-1 knockdown do not rescue development 
makes it unlikely that the rescue is mediated by some general increase in stress resistance or lifespan-
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increasing pathways. Even so, it was surprising to us that knockdown of transcription factors daf-16, 
pha-4, skn-1 failed to prevent the rescue phenotype. These transcription factors are essential for stress 
resistance and lifespan extension produced by inhibiting components of the mTOR pathway. In addition, 
we saw no evidence across 65, either predicted to be targets of S6K or proteins known to interact 
functionally with S6K, of RNAi inhibition rescuing development of hsf-1(sy441) mutants, or having a 
more severe effect on the development of hsf-1(sy441); rsks-1 double mutants vs. wild-type. While we 
cannot be sure from these experiments of the efficacy of each individual RNAi clone, in each experiment 
positive controls were present, and in some cases a visible phenotype (other than rescue) was produced 
by the RNAi clone, such as loss of eggs in animals with inhibited pha-4.  
Despite the rsks-1 mutants requiring some level of hsf-1 function to rescue the hsf-1(sy441) 
arrest phenotype, we saw no evidence of an activation of known hsf-1-activated genes or other stress-
response pathways. In yeast, only two heat-shock proteins are required to rescue the loss of hsf-1 for 
development (Solís et al. 2016), therefore it is possible that one or more unmeasured or non-canonical 
heat-shock proteins are independently regulated by hsf-1 and rsks-1, and it is through this unknown 
gene(s) that development is being rescued. For instance, Baird et al. previously showed that 
overexpression of the sy441 allele improves cytoskeletal integrity through up-regulation of pat-10. We 
did not test the effects on rsks-1 mutation on cytoskeletal integrity, so it remains a possible explanation 
for the rescue phenotype caused by rsks-1 mutation. 
It was surprising to note that the hsf-1(sy441) mutant animals showed more thermotolerance 
than wild-type controls. hsf-1(sy441) is considered an hsf-1 hypomorph primarily based on the finding 
that it significantly reduces the induction of hsp-16.2 in response to heat shock (Hajdu-Cronin et al. 
2004) and it reduces lifespan (if to a slightly smaller magnitude) similar to hsf-1 RNAi (Seo et al. 2013). 
However, I have shown that while hsf-1(sy441) does show less expression of hsp-16.2, the mutation has 
no effect on hsp-70 (F44E5.4) expression, and the hsf-1(sy441) mutants also seem to have increased 
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thermotolerance. In another publication, McColl et al. showed that hsf-1(sy441) had the same level of 
thermotolerance as wild-type. I speculate that hsf-1(sy441) may be hypomorphic for only a subset of 
HSF-1 targets and that the organismal response to an extreme and deadly heat stress may be regulated 
by input from other pathways that differ between backgrounds, leading to presence or absence of 
thermotolerance in hsf-1(sy441) in different laboratories. It is also possible that differing methods of 
toxic heat stress differ in an unknown but crucial way that alters results between labs. The main focus of 
my study was development rather than thermotolerance, but this observation remains an interesting 
avenue for investigation. 
Most of the experiments in this study involved either modulating the expression levels of genes 
with RNAi or measuring expression levels through RT-qPCR. As a kinase, it is possible that protein S6K 
modulates the activity of proteins directly without affecting expression levels. If such an activity increase 
activated the heat-shock response, the ER UPR, or the mito-UPR broadly, we would expect to measure 
that through an increased expression of canonical target genes, but it is possible that S6 kinase 
phosphorylates specific proteins in these pathways to mediate developmental arrest. This would be 
interesting to investigate in the future.        
In conclusion, a genetic screen for suppressors of the developmental growth arrest of hsf-
1(sy441) partial loss-of-function mutants revealed a previously unknown relationship between heat-
shock factor and mTOR/S6 kinase activity. Reducing S6 kinase activity allows animals with insufficient 
HSF-1 activity to progress much further through the life cycle than would otherwise be possible. Because 
heat-shock factor is known to enhance proteostasis under conditions of heat stress, we propose that 
loss of S6 kinase postpones arrest either by reducing the levels of damaged macromolecules produced in 
the cell, or by increasing the cell’s ability to remove or repair them.   
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Chapter 4: Conclusion 
 Aging is a complex, whole-organism phenotype that changes over time as the result of many 
interacting genetic and cellular processes. Understanding aging is not only an engaging scientific 
challenge, but it is also an avenue by which we might ameliorate broad swaths of human suffering. For 
my thesis project at UCSF I have worked to elucidate two specific aspects of aging: regulation by the 
nervous system, and the nature of a transcription factor integral to the aging process. 
 In Chapter 2 I investigated the mechanism by which a single gustatory neuron pair, ASI, 
regulates lifespan. I showed that, similar to ablation of the neuron pair, silencing the chemical signaling 
of ASI with ASI-specific expression of tetanus toxin extends lifespan and likely does so through reducing 
secretion of DAF-7/ TGFβ, inhibiting the IIS pathway, and activating DAF-16. This simple explanation, 
however, belies some interesting but confusing findings. While daf-16 is entirely required for daf-7 
mutants to increase lifespan it is only mostly required for silencing-ASI to do so. In addition, while 
almost 100% of daf-7 mutants form dauers at 25°C, animals with silenced-ASI form no dauers and 
ablated-ASI animals form an amount somewhere in between. A difference between ablating and 
silencing is also seen with respect to the gustatory neuron pair ASJ, in which I saw remarkably different 
lifespan effects in the silenced strain than has been previously reported in the case of ablation. These 
results together hint at a more complex regulation of lifespan than ASI as a simple nutrient detector 
which raises or lowers the secretion of DAF-7 and thereby affects lifespan. The intra-neuron 
communications and eventual chemical signals other than DAF-7 that alter lifespan remain to be 
discovered. It would be interesting to see how more dynamic perturbations to the signaling of a single 
neuron affect both the neuronal activity of other neurons as well as their transcriptomes to eventually 
affect lifespan. Such an approach is made possible through technologies such as optogenetics, calcium 
indicators, single-neuron RNA-seq, and single-neuron RNAi. Unlike genetic deletions of important 
signaling molecules or wide-scale disruption of the nervous system, single neuron perturbation might 
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better reflect endogenous signals from the worm nervous system that regulate its lifespan in a natural 
context.  
 After investigating how primary sensory neurons, arguably one of the most upstream effectors 
of lifespan, regulate the process of aging, I investigated in Chapter 3 how two fundamental cellular 
processes, the heat shock response and the mTOR pathway, communicate with one another. I found 
that the arrest phenotype caused by loss of hsf-1 function can be greatly ameliorated, but not 
completely rescued, by mutation of ribosomal S6 kinase and reduced-mTOR signaling more generally. 
This rescue is not due to a reduction in translation alone, and it is also not mediated through a variety of 
transcription factors and other genes known to interact with the mTOR pathway or play a role in 
lifespan. A mutation in S6 kinase normally extends lifespan but fails to do so in the hsf-1(sy441) mutant 
background, which, along with my studies, reveals a previously unknown reciprocal relationship 
between rsks-1 and hsf-1: in one case, low levels of S6 kinase cause endogenous levels of HSF-1 to 
extend lifespan, whereas in the other case, low levels of HSF-1 cause endogenous levels of S6 kinase to 
arrest development.  
I see two primary paths forward to further investigate this phenomenon of hsf-1(sy441) 
developmental arrest. The first is to collect large data sets to compare the single and double mutants. 
While I was able to find micro array and rna-seq datasets for rsks-1 and hsf-1(sy441) mutants, there 
exists no such data set for animals carrying both mutations. Furthermore, because RSKS-1 is a kinase 
which regulates translation, proteomic and phosphoproteomic datasets may be even more helpful in 
determining how the developmental rescue phenotype is mediated. The second path is to focus not on 
the link between loss of rsks-1 and developmental rescue but rather on the developmental arrest 
phenotype itself. What is the relationship between higher temperature, time exposed to higher 
temperature, and percentage of animals which arrest? Perplexingly, five different complementary 
suppressor mutations all produced animals with a similarly reduced size. Could it be that some aspect of 
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animal size or cell size rather than translation rate causes toxicity? A better understanding of precisely 
what deficit is causing arrest would inform a model of how rsks-1 mutation rescues that deficit. 
Modulation of both the mTOR pathway and the heat shock pathway are avenues being explored 
to improve human health, and while both may be able to improve cellular function over the lifespan, 
alterations in function may have implications for unwanted side effects such as reduced immune 
function or increased cancer risk. Communication between the two pathways may therefore prove 
important for effective optimization of pharmacological or other interventions. While I was not able to 
discover a molecular intermediate that facilitates communication between rsks-1 and hsf-1, the 
discovery of such an intermediate remains an exciting direction for future research. 
  
   
61 
 
References: 
Alam, H., Williams, T.W., Dumas, K.J., Guo, C., Yoshina, S., Mitani, S., and Hu, P.J. (2010). EAK-7 controls 
development and life span by regulating nuclear DAF-16/FoxO activity. Cell Metab. 12, 30–41. 
Alcedo, J., and Kenyon, C. (2004). Regulation of C. elegans Longevity by Specific Gustatory and Olfactory 
Neurons. Neuron 41, 45–55. 
Alcedo, J., Flatt, T., and Pasyukova, E.G. (2013). Neuronal Inputs and Outputs of Aging and Longevity. 
Front Genet 4. 
Apfeld, J., and Kenyon, C. (1998). Cell Nonautonomy of C. elegans daf-2 Function in the Regulation of 
Diapause and Life Span. Cell 95, 199–210. 
Apfeld, J., and Kenyon, C. (1999). Regulation of lifespan by sensory perception in Caenorhabditis 
elegans. Nature 402, 804–809. 
Baird, N.A., Douglas, P.M., Simic, M.S., Grant, A.R., Moresco, J.J., Wolff, S.C., Yates, J.R., Manning, G., and 
Dillin, A. (2014). HSF-1-mediated cytoskeletal integrity determines thermotolerance and life 
span. Science 346, 360–363. 
Beeton, M., and Pearson, K. (1899). Data for the Problem of Evolution in Man. II. A First Study of the 
Inheritance of Longevity and the Selective Death-Rate in Man. Proceedings of the Royal Society 
of London 65, 290–305. 
Berg, B.N., and Simms, H.S. (1961). Nutrition and Longevity in the RatIII. Food Restriction Beyond 800 
Days. J Nutr 74, 23–32. 
Berman, J.R., and Kenyon, C. (2006). Germ-cell loss extends C. elegans life span through regulation of 
DAF-16 by kri-1 and lipophilic-hormone signaling. Cell 124, 1055–1068. 
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71–94. 
62 
 
Chang, Y., Ostling, P., Akerfelt, M., Trouillet, D., Rallu, M., Gitton, Y., El Fatimy, R., Fardeau, V., Le Crom, 
S., Morange, M., et al. (2006). Role of heat-shock factor 2 in cerebral cortex formation and as a 
regulator of p35 expression. Genes Dev. 20, 836–847. 
Chen, D., Li, P.W.-L., Goldstein, B.A., Cai, W., Thomas, E.L., Chen, F., Hubbard, A.E., Melov, S., and 
Kapahi, P. (2013). Germline signaling mediates the synergistically prolonged longevity produced 
by double mutations in daf-2 and rsks-1 in C. elegans. Cell Rep 5, 1600–1610. 
Christians, E., Davis, A.A., Thomas, S.D., and Benjamin, I.J. (2000). Embryonic development: Maternal 
effect of Hsf1 on reproductive success. Nature 407, 693–694. 
Colman, R.J., Anderson, R.M., Johnson, S.C., Kastman, E.K., Kosmatka, K.J., Beasley, T.M., Allison, D.B., 
Cruzen, C., Simmons, H.A., Kemnitz, J.W., et al. (2009). Caloric restriction delays disease onset 
and mortality in rhesus monkeys. Science 325, 201–204. 
Conti, B., Sanchez-Alavez, M., Winsky-Sommerer, R., Morale, M.C., Lucero, J., Brownell, S., Fabre, V., 
Huitron-Resendiz, S., Henriksen, S., Zorrilla, E.P., et al. (2006). Transgenic mice with a reduced 
core body temperature have an increased life span. Science 314, 825–828. 
Dalfó, D., Michaelson, D., and Hubbard, E.J.A. (2012). Sensory regulation of reproduction via TGFβ 
signaling through the stem cell niche. Curr Biol 22, 712–719. 
Dillin, A., Hsu, A.-L., Arantes-Oliveira, N., Lehrer-Graiwer, J., Hsin, H., Fraser, A.G., Kamath, R.S., Ahringer, 
J., and Kenyon, C. (2002). Rates of Behavior and Aging Specified by Mitochondrial Function 
During Development. Science 298, 2398–2401. 
Drori, D., and Folman, Y. (1976). Environmental effects on longevity in the male rat: Exercise, mating, 
castration and restricted feeding. Experimental Gerontology 11, 25–32. 
Flatt, T. (2012). A New Definition of Aging? Front Genet 3. 
Friedman, D.B., and Johnson, T.E. (1988). A mutation in the age-1 gene in Caenorhabditis elegans 
lengthens life and reduces hermaphrodite fertility. Genetics 118, 75–86. 
63 
 
Fukuyama, M., Sakuma, K., Park, R., Kasuga, H., Nagaya, R., Atsumi, Y., Shimomura, Y., Takahashi, S., 
Kajiho, H., Rougvie, A., et al. (2012). C. elegans AMPKs promote survival and arrest germline 
development during nutrient stress. Biology Open 1, 929–936. 
Furuyama, T., Nakazawa, T., Nakano, I., and Mori, N. (2000). Identification of the differential distribution 
patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. 
J. 349, 629–634. 
Garigan, D., Hsu, A.-L., Fraser, A.G., Kamath, R.S., Ahringer, J., and Kenyon, C. (2002). Genetic analysis of 
tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. 
Genetics 161, 1101–1112. 
Glaser, R.W. (1923). The effect of food on longevity and reproduction in flies. Journal of Experimental 
Zoology 38, 383–412. 
Hajdu-Cronin, Y.M., Chen, W.J., and Sternberg, P.W. (2004). The L-type cyclin CYL-1 and the heat-shock-
factor HSF-1 are required for heat-shock-induced protein expression in Caenorhabditis elegans. 
Genetics 168, 1937–1949. 
Hansen Malene, Taubert Stefan, Crawford Douglas, Libina Nataliya, Lee Seung‐Jae, and Kenyon Cynthia 
(2006). Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging 
Cell 6, 95–110. 
Haydak, M.H. (1953). Influence of the Protein Level of the Diet on the Longevity of Cockroaches. Ann 
Entomol Soc Am 46, 547–560. 
Hayflick, L. (2007). Entropy Explains Aging, Genetic Determinism Explains Longevity, and Undefined 
Terminology Explains Misunderstanding Both. PLoS Genet 3. 
van Heemst, D. (2010). Insulin, IGF-1 and longevity. Aging Dis 1, 147–157. 
64 
 
Honda, Y., and Honda, S. (1999). The daf-2 gene network for longevity regulates oxidative stress 
resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB 
J. 13, 1385–1393. 
Hoogewijs, D., Houthoofd, K., Matthijssens, F., Vandesompele, J., and Vanfleteren, J.R. (2008). Selection 
and validation of a set of reliable reference genes for quantitative sod gene expression analysis 
in C. elegans. BMC Mol. Biol. 9, 9. 
Hsin, H., and Kenyon, C. (1999). Signals from the reproductive system regulate the lifespan of C. elegans. 
Nature 399, 362–366. 
Jansen, G., Thijssen, K.L., Werner, P., van derHorst, M., Hazendonk, E., and Plasterk, R.H.A. (1999). The 
complete family of genes encoding G proteins of Caenorhabditis elegans. Nature Genetics 21, 
414–419. 
Jedlicka, P., Mortin, M.A., and Wu, C. (1997). Multiple functions of Drosophila heat shock transcription 
factor in vivo. The EMBO Journal 16, 2452–2462. 
Jia, K., Chen, D., and Riddle, D.L. (2004). The TOR pathway interacts with the insulin signaling pathway to 
regulate C. elegans larval development, metabolism and life span. Development 131, 3897–
3906. 
Kenyon, C.J. (2010). The genetics of ageing. 
Kenyon, C., Chang, J., Gensch, E., Rudner, A., and Tabtiang, R. (1993). A C. elegans mutant that lives 
twice as long as wild type. Nature 366, 461–464. 
Kimura, K.D., Tissenbaum, H.A., Liu, Y., and Ruvkun, G. (1997). daf-2, an Insulin Receptor-Like Gene That 
Regulates Longevity and Diapause in Caenorhabditis elegans. Science 277, 942–946. 
Klass, M.R. (1977). Aging in the nematode Caenorhabditis elegans: major biological and environmental 
factors influencing life span. Mech. Ageing Dev. 6, 413–429. 
65 
 
Klass, M.R. (1983). A method for the isolation of longevity mutants in the nematode Caenorhabditis 
elegans and initial results. Mechanisms of Ageing and Development 22, 279–286. 
Lee, S.-J., and Kenyon, C. (2009). Regulation of the Longevity Response to Temperature by 
Thermosensory Neurons in Caenorhabditis elegans. Curr Biol 19, 715–722. 
Lee, S.-J., Hwang, A.B., and Kenyon, C. (2010). Inhibition of respiration extends C. elegans’ lifespan via 
reactive oxygen species that increase HIF-1 activity. Curr Biol 20, 2131–2136. 
Li, J., Chauve, L., Phelps, G., Brielmann, R.M., and Morimoto, R.I. (2016). E2F coregulates an essential 
HSF developmental program that is distinct from the heat-shock response. Genes Dev 30, 2062–
2075. 
Li, J., Labbadia, J., and Morimoto, R.I. (2017). Rethinking HSF1 in Stress, Development, and Organismal 
Health. Trends in Cell Biology 27, 895–905. 
Libert, S., Zwiener, J., Chu, X., Vanvoorhies, W., Roman, G., and Pletcher, S.D. (2007). Regulation of 
Drosophila life span by olfaction and food-derived odors. Science 315, 1133–1137. 
Libina, N., Berman, J.R., and Kenyon, C. (2003). Tissue-Specific Activities of C. elegans DAF-16 in the 
Regulation of Lifespan. Cell 115, 489–502. 
Lin, K., Dorman, J.B., Rodan, A., and Kenyon, C. (1997). daf-16: An HNF-3/forkhead family member that 
can function to double the life-span of Caenorhabditis elegans. Science 278, 1319–1322. 
Liu, T., and Cai, D. (2013). Counterbalance between BAG and URX neurons via guanylate cyclases 
controls lifespan homeostasis in C. elegans. EMBO J 32, 1529–1542. 
MacArthur, J.W., and Baillie, W.H.T. (1929). Metabolic activity and duration of life. I. Influence of 
temperature on longevity in Daphnia magna. Journal of Experimental Zoology 53, 221–242. 
Macosko, E.Z., Pokala, N., Feinberg, E.H., Chalasani, S.H., Butcher, R.A., Clardy, J., and Bargmann, C.I. 
(2009). A Hub-and-Spoke Circuit Drives Pheromone Attraction and Social Behavior in C. elegans. 
Nature 458, 1171–1175. 
66 
 
Magnuson, B., Ekim, B., and Fingar, D.C. (2012). Regulation and function of ribosomal protein S6 kinase 
(S6K) within mTOR signalling networks. Biochem. J. 441, 1–21. 
Mattison, J.A., Roth, G.S., Beasley, T.M., Tilmont, E.M., Handy, A.H., Herbert, R.L., Longo, D.L., Allison, 
D.B., Young, J.E., Bryant, M., et al. (2012). Impact of caloric restriction on health and survival in 
rhesus monkeys: the NIA study. Nature 489. 
McCay, C.M., Maynard, L.A., Sperling, G., and Barnes, L.L. (1975). The Journal of Nutrition. Volume 18 
July--December, 1939. Pages 1--13. Retarded growth, life span, ultimate body size and age 
changes in the albino rat after feeding diets restricted in calories. Nutr. Rev. 33, 241–243. 
McColl, G., Rogers, A.N., Alavez, S., Hubbard, A.E., Melov, S., Link, C.D., Bush, A.I., Kapahi, P., and 
Lithgow, G.J. (2010). Insulin-like signaling determines survival during stress via 
posttranscriptional mechanisms in C. elegans. Cell Metab. 12, 260–272. 
McMahon, H.T., Foran, P., Dolly, J.O., Verhage, M., Wiegant, V.M., and Nicholls, D.G. (1992). Tetanus 
toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, 
and met-enkephalin release from synaptosomes. Clues to the locus of action. J. Biol. Chem. 267, 
21338–21343. 
McMillan, D.R., Xiao, X., Shao, L., Graves, K., and Benjamin, I.J. (1998). Targeted disruption of heat shock 
transcription factor 1 abolishes thermotolerance and protection against heat-inducible 
apoptosis. J. Biol. Chem. 273, 7523–7528. 
Meisel, J.D., Panda, O., Mahanti, P., Schroeder, F.C., and Kim, D.H. (2014). Chemosensation of Bacterial 
Secondary Metabolites Modulates Neuroendocrine Signaling and Behavior of C. elegans. 
Cell 159, 267–280. 
Morley, J.F., and Morimoto, R.I. (2004). Regulation of Longevity in Caenorhabditis elegans by Heat Shock 
Factor and Molecular Chaperones. Mol Biol Cell 15, 657–664. 
67 
 
Murphy, C.T., and Hu, P.J. (2013). Insulin/insulin-like growth factor signaling in C. elegans. WormBook 1–
43. 
Murphy, C.T., Lee, S.-J., and Kenyon, C. (2007). Tissue entrainment by feedback regulation of insulin 
gene expression in the endoderm of Caenorhabditis elegans. Proc Natl Acad Sci U S A 104, 
19046–19050. 
Ogg, S., Paradis, S., Gottlieb, S., Patterson, G.I., Lee, L., Tissenbaum, H.A., and Ruvkun, G. (1997). The 
Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in 
C. elegans. Nature 389, 994–999. 
Pan, K.Z., Palter, J.E., Rogers, A.N., Olsen, A., Chen, D., Lithgow, G.J., and Kapahi, P. (2007). Inhibition of 
mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 6, 111–119. 
Pearl, R. (1931). Studies on Human Longevity. IV. The Inheritance of Longevity. Preliminary Report. 
Human Biology; Baltimore 3, 245–269. 
Ren, P., Lim, C.-S., Johnsen, R., Albert, P.S., Pilgrim, D., and Riddle, D.L. (1996). Control of C. elegans 
Larval Development by Neuronal Expression of a TGF-β Homolog. Science 274, 1389–1391. 
Robida-Stubbs, S., Glover-Cutter, K., Lamming, D.W., Mizunuma, M., Narasimhan, S.D., Neumann-
Haefelin, E., Sabatini, D.M., and Blackwell, T.K. (2012). TOR signaling and rapamycin influence 
longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 15, 713–724. 
Santos, S.D., and Saraiva, M.J. (2004). Enlarged ventricles, astrogliosis and neurodegeneration in heat 
shock factor 1 null mouse brain. Neuroscience 126, 657–663. 
Schiavo, G.G., Benfenati, F., Poulain, B., Rossetto, O., Laureto, P.P. de, DasGupta, B.R., and Montecucco, 
C. (1992). Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic 
cleavage of synaptobrevin. Nature 359, 832–835. 
68 
 
Seo, K., Choi, E., Lee, D., Jeong, D.-E., Jang, S.K., and Lee, S.-J. (2013). Heat shock factor 1 mediates the 
longevity conferred by inhibition of TOR and insulin/IGF-1 signaling pathways in C. elegans. 
Aging Cell 12, 1073–1081. 
Shaw, W.M., Luo, S., Landis, J., Ashraf, J., and Murphy, C.T. (2007). The C. elegans TGF-beta Dauer 
pathway regulates longevity via insulin signaling. Curr. Biol. 17, 1635–1645. 
Sheaffer, K.L., Updike, D.L., and Mango, S.E. (2008). The Target of Rapamycin pathway antagonizes pha-
4/FoxA to control development and aging. Curr. Biol. 18, 1355–1364. 
Shen, X., Ellis, R.E., Lee, K., Liu, C.-Y., Yang, K., Solomon, A., Yoshida, H., Morimoto, R., Kurnit, D.M., Mori, 
K., et al. (2001). Complementary Signaling Pathways Regulate the Unfolded Protein Response 
and Are Required for C. elegans Development. Cell 107, 893–903. 
Solís, E.J., Pandey, J.P., Zheng, X., Jin, D.X., Gupta, P.B., Airoldi, E.M., Pincus, D., and Denic, V. (2016). 
Defining the Essential Function of Yeast Hsf1 Reveals a Compact Transcriptional Program for 
Maintaining Eukaryotic Proteostasis. Molecular Cell 63, 60–71. 
Stroustrup, N., Ulmschneider, B.E., Nash, Z.M., López Moyado, I.F., Apfeld, J., and Fontana, W. (2013). 
The C. elegans Lifespan Machine. Nat Methods 10, 665–670. 
Takaki, E., Fujimoto, M., Sugahara, K., Nakahari, T., Yonemura, S., Tanaka, Y., Hayashida, N., Inouye, S., 
Takemoto, T., Yamashita, H., et al. (2006). Maintenance of olfactory neurogenesis requires HSF1, 
a major heat shock transcription factor in mice. J. Biol. Chem. 281, 4931–4937. 
Tullet, J.M.A., Hertweck, M., An, J.H., Baker, J., Hwang, J.Y., Liu, S., Oliveira, R.P., Baumeister, R., and 
Blackwell, T.K. (2008). Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like 
signaling in C. elegans. Cell 132, 1025–1038. 
Van Gilst, M.R., Hadjivassiliou, H., Jolly, A., and Yamamoto, K.R. (2005). Nuclear hormone receptor NHR-
49 controls fat consumption and fatty acid composition in C. elegans. PLoS Biol. 3, e53. 
69 
 
Xiao, X., Zuo, X., Davis, A.A., McMillan, D.R., Curry, B.B., Richardson, J.A., and Benjamin, I.J. (1999). HSF1 
is required for extra-embryonic development, postnatal growth and protection during 
inflammatory responses in mice. EMBO J. 18, 5943–5952. 
Zhang, Y., Huang, L., Zhang, J., Moskophidis, D., and Mivechi, N.F. (2002). Targeted disruption of hsf1 
leads to lack of thermotolerance and defines tissue-specific regulation for stress-inducible Hsp 
molecular chaperones. J. Cell. Biochem. 86, 376–393. 
 
 
70 
 
Tables: 
Table 2.1: List of all lifespans conducted 
Experiment 
# 
Neuronal 
condition 
Genetic 
condition 
Median 
Lifespan 
Sample 
Size 
Automated? integrated 
construct or 
extrachromosomal 
1 Silenced-ASI 
 
17.5 71 yes integrated 
1 Wild-Type 
 
16.9 66 yes integrated 
1 Silenced-ASI daf-3(RNAi) 15.6 166 yes integrated 
1 Wild-Type daf-3(RNAi) 16.1 110 yes integrated 
1 Silenced-ASI hif-1(RNAi) 15.6 97 yes integrated 
1 Wild-Type hif-1(RNAi) 15 62 yes integrated 
1 Silenced-ASI hsf-1(RNAi) 17.3 153 yes integrated 
1 Wild-Type hsf-1(RNAi) 13.1 114 yes integrated 
2 Silenced-ASI 
 
17.1 84 yes integrated 
2 Wild-Type 
 
15.6 87 yes integrated 
2 Ablated-ASI 
 
17.8 69 yes integrated 
2 Silenced-ASI daf-16(RNAi) 12.4 77 yes integrated 
2 Wild-Type daf-16(RNAi) 12.5 92 yes integrated 
2 Ablated-ASI daf-16(RNAi) 12.5 69 yes integrated 
3 Silenced-ASI 
 
18 47 yes integrated 
3 Wild-Type 
 
16.3 70 yes integrated 
3 Ablated-ASI 
 
18.2 41 yes integrated 
3 Silenced-ASI daf-16(RNAi) 12.2 108 yes integrated 
3 Ablated-ASI daf-16(RNAi) 12.1 89 yes integrated 
3 Wild-Type daf-16(RNAi) 11.6 29 yes integrated 
4 Silenced-ASI 
 
18.7 159 yes integrated 
4 Wild-Type 
 
18.1 79 yes integrated 
4 Ablated-ASI 
 
19.6 145 yes integrated 
4 Silenced-ASJ 
 
14.7 88 yes integrated 
4 Silenced-ASI; 
Silenced-ASI 
 
17.3 157 yes integrated 
4 Silenced-ASJ; 
Ablated-ASI 
 
19.3 121 yes integrated 
5 Wild-Type 
 
11.2 153 yes integrated 
5 Wild-Type daf-3(mgdf90) 10.5 46 yes integrated 
5 Ablated-ASI 
 
13.4 102 yes integrated 
5 Ablated-ASI daf-3(mgdf90) 10.1 35 yes integrated 
6 Wild-Type daf-3(mgdf90) 19 63 no integrated 
6 Silenced-ASI daf-3(mgdf90) 19 49 no integrated 
7 Wild-Type 
 
16 94 no integrated 
7 Wild-Type hsf-1(RNAi) 11 86 no integrated 
71 
 
Experiment 
# 
Neuronal 
condition 
Genetic 
condition 
Median 
Lifespan 
Sample 
Size 
Automated? integrated 
construct or 
extrachromosomal 
7 Silenced-ASI hsf-1(RNAi) 16 87 no integrated 
7 Ablated-ASI hsf-1(RNAi) 9 79 no integrated 
8 Wild-Type 
 
18 46 no integrated 
8 Wild-Type hsf-1(RNAi) 15 82 no integrated 
8 Silenced-ASI 
 
22 82 no integrated 
8 Silenced-ASI hsf-1(RNAi) 20 90 no integrated 
8 Ablated-ASI 
 
20 49 no integrated 
8 Ablated-ASI hsf-1(RNAi) 15 91 no integrated 
9 Silenced-ASI 
 
16.3 156 yes extrachromosomal 
9 Wild-Type 
 
14.1 86 yes extrachromosomal 
9 Silenced-ASI daf-3(mgdf90) 14.4 167 yes extrachromosomal 
9 Wild-Type daf-3(mgdf90) 14.6 165 yes extrachromosomal 
9 Silenced-ASI kri-1(ok1251) 21.3 134 yes extrachromosomal 
9 Wild-Type kri-1(ok1251) 20.4 59 yes extrachromosomal 
10 Silenced-ASI 
 
17 66 no extrachromosomal 
10 Wild-Type 
 
15 55 no extrachromosomal 
10 Silenced-ASI 
 
15.9 141 yes extrachromosomal 
10 Wild-Type 
 
13.4 93 yes extrachromosomal 
10 Silenced-ASI daf-16(RNAi) 11.3 84 yes extrachromosomal 
10 Wild-Type daf-16(RNAi) 10.8 119 yes extrachromosomal 
11 Silenced-ASI 
 
16.9 118 yes extrachromosomal 
11 Wild-Type 
 
14.4 110 yes extrachromosomal 
12 Ablated-ASI 
(ablated with 
a laser) 
 
23 18 no extrachromosomal 
12 Wild-Type 
 
21 28 no extrachromosomal 
13 Silenced-ASI daf-16(mu86) 13.1 36 yes extrachromosomal 
13 Wild-Type daf-16(mu86) 10.9 51 yes extrachromosomal 
14 Wild-Type daf-16(mu86) 15 130 no extrachromosomal 
14 Silenced-ASI daf-16(mu86) 17 98 no extrachromosomal 
15 Wild-Type 
 
21 68 no extrachromosomal 
15 Wild-Type hsf-1(RNAi) 14 117 no extrachromosomal 
15 Silenced-ASI 
 
23 98 no extrachromosomal 
15 Silenced-ASI hsf-1(RNAi) 14 125 no extrachromosomal 
16 Wild-Type daf-16(RNAi) 13 145 no extrachromosomal 
16 Ablated-ASI daf-16(RNAi) 14 124 no integrated 
16 Silenced-ASI daf-16(RNAi) 13 167 no extrachromosomal 
16 Wild-Type daf-16(RNAi) 13 172 no extrachromosomal 
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Experiment 
# 
Neuronal 
condition 
Genetic 
condition 
Median 
Lifespan 
Sample 
Size 
Automated? integrated 
construct or 
extrachromosomal 
16 Ablated-ASI 
crossed with 
Silenced-ASI 
expressing 
background 
daf-16(RNAi) 15 154 no extrachromosomal 
16 Ablated ASI 
crossed with 
non-
expresssing 
Silenced-ASI 
background 
daf-16(RNAi) 14 149 no extrachromosomal 
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Table 3.1: Table of conditions that reduced translation. 
 
Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 1 hsf-1(sy441) daf-15  52 42 44.7 
Experim
ent 1 hsf-1(sy441) ifg-1 1%  65 31 32.3 
Experim
ent 1 hsf-1(sy441) ifg-1 16%  68 11 13.9 
Experim
ent 1 hsf-1(sy441) ifg-1 2%  66 59 47.2 
Experim
ent 1 hsf-1(sy441) ifg-1 32%  102 0 0.0 
Experim
ent 1 hsf-1(sy441) ifg-1 4%  79 26 24.8 
Experim
ent 1 hsf-1(sy441) ifg-1 8%  86 9 9.5 
Experim
ent 1 hsf-1(sy441) Vector Control  76 44 36.7 
Experim
ent 1 
hsf-1(sy441); 
rsks-1(mu482) Vector Control  0 136 100.0 
Experim
ent 1 
hsf-1(sy441); 
rsks-1(sv31) Vector Control  0 63 100.0 
Experim
ent 1 wild-type ifg-1 16%  1 76 98.7 
Experim
ent 1 wild-type ifg-1 32%  6 70 92.1 
Experim
ent 1 wild-type ifg-1 4%  0 67 100.0 
Experim
ent 1 wild-type ifg-1 8%  1 71 98.6 
Experim
ent 2 hsf-1(sy441) ifg-1 1%  44 16 26.7 
Experim
ent 2 hsf-1(sy441) ifg-1 100%  98 0 0.0 
Experim
ent 2 hsf-1(sy441) ifg-1 16%  83 6 6.7 
Experim
ent 2 hsf-1(sy441) ifg-1 2%  78 12 13.3 
Experim
ent 2 hsf-1(sy441) ifg-1 32%  76 0 0.0 
Experim
ent 2 hsf-1(sy441) ifg-1 4%  22 7 24.1 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 2 hsf-1(sy441) ifg-1 8%  83 8 8.8 
Experim
ent 2 hsf-1(sy441) rsks-1  41 62 60.2 
Experim
ent 2 hsf-1(sy441) Vector Control  94 29 23.6 
Experim
ent 2 
hsf-1(sy441); 
rsks-1(mu482) ifg-1 32%  8 30 78.9 
Experim
ent 2 
hsf-1(sy441); 
rsks-1(mu482) Vector Control  1 37 97.4 
Experim
ent 2 wild-type ifg-1 100%  55 1 1.8 
Experim
ent 2 wild-type ifg-1 16%  9 46 83.6 
Experim
ent 2 wild-type ifg-1 32%  17 43 71.7 
Experim
ent 3 hsf-1(sy441) rps-6 1.5%  73 4 5.2 
Experim
ent 3 hsf-1(sy441) rps-6 100%  157 0 0.0 
Experim
ent 3 hsf-1(sy441) rps-6 12.5%  23 0 0.0 
Experim
ent 3 hsf-1(sy441) rps-6 25%  105 2 1.9 
Experim
ent 3 hsf-1(sy441) rps-6 50%  126 0 0.0 
Experim
ent 3 hsf-1(sy441) rsks-1  55 65 54.2 
Experim
ent 3 hsf-1(sy441) Vector Control  103 47 31.3 
Experim
ent 3 
hsf-1(sy441); 
rsks-1(mu482) rps-6 100%  134 8 5.6 
Experim
ent 3 
hsf-1(sy441); 
rsks-1(mu482) Vector Control  0 138 100.0 
Experim
ent 3 wild-type rps-6 1.5%  0 87 100.0 
Experim
ent 3 wild-type rps-6 100%  76 0 0.0 
Experim
ent 3 wild-type rps-6 12.5%  3 58 95.1 
Experim
ent 3 wild-type rps-6 25%  15 57 79.2 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 3 wild-type rps-6 3.125%  0 103 100.0 
Experim
ent 3 wild-type rps-6 50%  58 11 15.9 
Experim
ent 3 wild-type rps-6 6.25%  0 97 100.0 
Experim
ent 4 hsf-1(sy441) ifg-1 1%  77 58 43.0 
Experim
ent 4 hsf-1(sy441) ifg-1 100%  138 4 2.8 
Experim
ent 4 hsf-1(sy441) ifg-1 16%  103 4 3.7 
Experim
ent 4 hsf-1(sy441) ifg-1 2%  57 53 48.2 
Experim
ent 4 hsf-1(sy441) ifg-1 32%  112 5 4.3 
Experim
ent 4 hsf-1(sy441) ifg-1 4%  87 39 31.0 
Experim
ent 4 hsf-1(sy441) ifg-1 8%  120 17 12.4 
Experim
ent 4 hsf-1(sy441) rsks-1  22 158 87.8 
Experim
ent 4 hsf-1(sy441) Vector Control  158 60 27.5 
Experim
ent 4 
hsf-1(sy441); 
rsks-1(mu482) ifg-1 100%  78 42 35.0 
Experim
ent 4 
hsf-1(sy441); 
rsks-1(mu482) ifg-1 16%  0 110 100.0 
Experim
ent 4 
hsf-1(sy441); 
rsks-1(mu482) ifg-1 32%  25 71 74.0 
Experim
ent 4 
hsf-1(sy441); 
rsks-1(mu482) ifg-1 8%  6 137 95.8 
Experim
ent 4 
hsf-1(sy441); 
rsks-1(mu482) Vector Control   0 142 100.0 
Experim
ent 4 wild-type ifg-1 16%  8 133 94.3 
Experim
ent 4 wild-type ifg-1 32%  6 127 95.5 
Experim
ent 4 wild-type ifg-1 8%  0 113 100.0 
Experim
ent 5 wild-type Vector Control 0.37% DMSO 0 110 100.0 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 5 wild-type Vector Control 
2.9uM 
salubrinal  2 90 97.8 
Experim
ent 5 wild-type Vector Control 
185.2uM 
salubrinal  10 84 89.4 
Experim
ent 5 wild-type Vector Control 
23.1uM 
salubrinal  6 84 93.3 
Experim
ent 5 wild-type Vector Control 
362nM 
salubrinal  0 98 100.0 
Experim
ent 5 wild-type Vector Control 
46.3uM 
salubrinal  2 110 98.2 
Experim
ent 5 wild-type Vector Control 
5.8uM 
salubrinal  1 106 99.1 
Experim
ent 5 wild-type Vector Control 
723nM 
salubrinal  2 128 98.5 
Experim
ent 5 wild-type Vector Control 
92.6uM 
salubrinal  2 100 98.0 
Experim
ent 5 wild-type Vector Control 
11.6uM 
salubrinal  8 72 90.0 
Experim
ent 5 wild-type Vector Control 
1.4uM 
salubrinal  0 107 100.0 
Experim
ent 6 wild-type Vector Control 0.1% DMSO 0 107 100.0 
Experim
ent 6 wild-type Vector Control 
2.9uM 
harringtonine  0 108 100.0 
Experim
ent 6 wild-type Vector Control 
185.2uM 
harringtonine  87 20 18.7 
Experim
ent 6 wild-type Vector Control 
23.1uM 
harringtonine  1 97 99.0 
Experim
ent 6 wild-type Vector Control 
362nM 
harringtonine  2 102 98.1 
Experim
ent 6 wild-type Vector Control 
370.4uM 
harringtonine  40 55 57.9 
Experim
ent 6 wild-type Vector Control 
46.3uM 
harringtonine  1 101 99.0 
Experim
ent 6 wild-type Vector Control 
5.8uM 
harringtonine  0 78 100.0 
Experim
ent 6 wild-type Vector Control 
723nM 
harringtonine  0 77 100.0 
Experim
ent 6 wild-type Vector Control 
92.6uM 
harringtonine  29 60 67.4 
Experim
ent 6 wild-type Vector Control 
11.6uM 
harringtonine  0 94 100.0 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 6 wild-type Vector Control 
1.4uM 
harringtonine  0 85 100.0 
Experim
ent 7 hsf-1(sy441) rps-6 0.09%  92 27 22.7 
Experim
ent 7 hsf-1(sy441) rps-6 0.18%  87 52 37.4 
Experim
ent 7 hsf-1(sy441) rps-6 0.37%  44 79 64.2 
Experim
ent 7 hsf-1(sy441) rps-6 0.75%  80 55 40.7 
Experim
ent 7 hsf-1(sy441) rps-6 1.5%  107 80 42.8 
Experim
ent 7 hsf-1(sy441) rps-6 12.5%   105 46 30.5 
Experim
ent 7 hsf-1(sy441) rps-6 3.125%   75 39 34.2 
Experim
ent 7 hsf-1(sy441) rps-6 6.25%   68 44 39.3 
Experim
ent 7 hsf-1(sy441) Vector Control  82 72 46.8 
Experim
ent 7 wild-type rps-6 100%  76 16 17.4 
Experim
ent 7 wild-type rps-6 12.5%   0 128 100.0 
Experim
ent 7 wild-type rps-6 25%   33 127 79.4 
Experim
ent 7 wild-type rps-6 50%  56 45 44.6 
Experim
ent 7 wild-type rps-6 6.5%   0 103 100.0 
Experim
ent 7 wild-type Vector Control  0 101 100.0 
Experim
ent 8 
hsf-1(sy441); 
rsks-1(mu482) Vector Control  1 158 99.4 
Experim
ent 8 hsf-1(sy441) rps-6 0.045%   76 77 50.3 
Experim
ent 8 hsf-1(sy441) rps-6 0.09%  60 72 54.5 
Experim
ent 8 hsf-1(sy441) rps-6 0.18%  82 78 48.8 
Experim
ent 8 hsf-1(sy441) rps-6 0.37%   27 38 58.5 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 8 hsf-1(sy441) rps-6 0.75%  52 79 60.3 
Experim
ent 8 hsf-1(sy441) rps-6 1.5%  52 39 42.9 
Experim
ent 8 hsf-1(sy441) rps-6 12.5%  80 70 46.7 
Experim
ent 8 hsf-1(sy441) rps-6 25%  72 48 40.0 
Experim
ent 8 hsf-1(sy441) rps-6 3.125%   38 85 69.1 
Experim
ent 8 hsf-1(sy441) rps-6 6.25%   107 109 50.5 
Experim
ent 8 hsf-1(sy441) rsks-1  27 116 81.1 
Experim
ent 8 hsf-1(sy441) Vector Control  62 110 64.0 
Experim
ent 8 
hsf-1(sy441); 
rsks-1(mu482) Vector Control  1 158 99.4 
Experim
ent 8 wild-type rps-6 100%   150 0 0.0 
Experim
ent 8 wild-type rps-6 12.5%   16 89 84.8 
Experim
ent 8 wild-type rps-6 25%  21 117 84.8 
Experim
ent 8 wild-type rps-6 50%  90 9 9.1 
Experim
ent 8 wild-type Vector Control  0 127 100.0 
Experim
ent 9 hsf-1(sy441) rps-6 0.045%   82 48 36.9 
Experim
ent 9 hsf-1(sy441) rps-6 0.09%   64 54 45.8 
Experim
ent 9 hsf-1(sy441) rps-6 0.18%   94 44 31.9 
Experim
ent 9 hsf-1(sy441) rps-6 0.37%   67 41 38.0 
Experim
ent 9 hsf-1(sy441) rps-6 0.75%   67 39 36.8 
Experim
ent 9 hsf-1(sy441) rps-6 1.5%   80 25 23.8 
Experim
ent 9 hsf-1(sy441) rps-6 12.5%   82 19 18.8 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 9 hsf-1(sy441) rps-6 25%   84 20 19.2 
Experim
ent 9 hsf-1(sy441) rps-6 3.125%   71 47 39.8 
Experim
ent 9 hsf-1(sy441) rps-6 6.25%   57 39 40.6 
Experim
ent 9 hsf-1(sy441) rsks-1  36 94 72.3 
Experim
ent 9 hsf-1(sy441) Vector Control  107 34 24.1 
Experim
ent 9 wild-type rps-6 100%   89 0 0.0 
Experim
ent 9 wild-type rps-6 12.5%   0 139 100.0 
Experim
ent 9 wild-type rps-6 25%   13 116 89.9 
Experim
ent 9 wild-type rps-6 50%   68 49 41.9 
Experim
ent 9 wild-type Vector Control  0 105 100.0 
Experim
ent 10 hsf-1(sy441) Vector Control 23nM salubrinal 57 12 17.4 
Experim
ent 10 hsf-1(sy441) Vector Control 45nM salubrinal 91 20 18.0 
Experim
ent 10 hsf-1(sy441) Vector Control 90nM salubrinal 87 7 7.4 
Experim
ent 10 hsf-1(sy441) Vector Control 
181nM 
salubrinal 97 7 6.7 
Experim
ent 10 hsf-1(sy441) Vector Control 0.37% DMSO 97 13 11.8 
Experim
ent 10 hsf-1(sy441) rsks-1 0.37%DMSO 55 20 26.7 
Experim
ent 10 hsf-1(sy441) Vector Control 
362nM 
salubrinal 67 21 23.9 
Experim
ent 10 hsf-1(sy441) Vector Control 
723nM 
salubrinal 66 28 29.8 
Experim
ent 10 hsf-1(sy441) Vector Control 
1.4uM 
salubrinal 54 22 28.9 
Experim
ent 10 hsf-1(sy441) Vector Control 
1.56uM 
salubrinal 82 5 5.7 
Experim
ent 10 hsf-1(sy441) Vector Control 
23.1uM 
salubrinal 68 1 1.4 
80 
 
Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 10 hsf-1(sy441) Vector Control 
5.8uM 
salubrinal 96 6 5.9 
Experim
ent 10 hsf-1(sy441) Vector Control 
11.6uM 
salubrinal 78 0 0.0 
Experim
ent 10 hsf-1(sy441) Vector Control  79 39 33.1 
Experim
ent 10 
hsf-1(sy441); 
rsks-1(mu482) Vector Control 
23.1uM 
salubrinal 68 10 12.8 
Experim
ent 10 wild-type Vector Control 0.37% DMSO 0 101 100.0 
Experim
ent 10 wild-type Vector Control 
5.8uM 
salubrinal 0 83 100.0 
Experim
ent 10 wild-type Vector Control 
11.6uM 
salubrinal 0 97 100.0 
Experim
ent 10 wild-type Vector Control  0 67 100.0 
Experim
ent 11 hsf-1(sy441) Vector Control 
181nM 
salubrinal 82 16 16.3 
Experim
ent 11 hsf-1(sy441) Vector Control 45nM salubrinal 82 19 18.8 
Experim
ent 11 hsf-1(sy441) Vector Control 90nM salubrinal 82 13 13.7 
Experim
ent 11 hsf-1(sy441) rsks-1 0.19%DMSO 11 7 38.9 
Experim
ent 11 hsf-1(sy441) Vector Control 0.19%DMSO 47 4 7.8 
Experim
ent 11 hsf-1(sy441) Vector Control 
181nM 
salubrinal 99 16 13.9 
Experim
ent 11 hsf-1(sy441) Vector Control 0.37% DMSO 83 7 7.8 
Experim
ent 11 hsf-1(sy441) Vector Control 
362nM 
salubrinal 95 12 11.2 
Experim
ent 11 hsf-1(sy441) Vector Control 
723nM 
salubrinal 87 33 27.5 
Experim
ent 11 hsf-1(sy441) Vector Control 
1.4uM 
salubrinal 69 19 21.6 
Experim
ent 11 hsf-1(sy441) Vector Control 
2.9uM 
salubrinal 96 19 16.5 
Experim
ent 11 hsf-1(sy441) Vector Control 
23.1uM 
salubrinal 90 3 3.2 
Experim
ent 11 hsf-1(sy441) Vector Control 
5.8uM 
salubrinal 74 6 7.5 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 11 hsf-1(sy441) Vector Control 
11.6uM 
salubrinal 81 1 1.2 
Experim
ent 11 hsf-1(sy441) Vector Control  48 27 36.0 
Experim
ent 11 
hsf-1(sy441); 
rsks-1(mu482) Vector Control 
5.8uM 
salubrinal 65 59 47.6 
Experim
ent 11 
hsf-1(sy441); 
rsks-1(mu482) Vector Control 
11.6uM 
salubrinal 51 21 29.2 
Experim
ent 11 wild-type Vector Control 
5.8uM 
salubrinal 0 101 100.0 
Experim
ent 11 wild-type Vector Control 
11.6uM 
salubrinal 0 100 100.0 
Experim
ent 12 hsf-1(sy441) rsks-1 0.19%DMSO 40 58 59.2 
Experim
ent 12 hsf-1(sy441) Vector Control 0.19%DMSO 90 40 30.8 
Experim
ent 12 hsf-1(sy441) Vector Control 
181nM 
harringtonine 137 49 26.3 
Experim
ent 12 hsf-1(sy441) Vector Control 
362nM 
harringtonine 126 37 22.7 
Experim
ent 12 hsf-1(sy441) Vector Control 
723nM 
harringtonine 111 37 25.0 
Experim
ent 12 hsf-1(sy441) Vector Control 
1.4uM 
harringtonine 110 21 16.0 
Experim
ent 12 hsf-1(sy441) Vector Control 
2.9uM 
harringtonine 135 23 14.6 
Experim
ent 12 hsf-1(sy441) Vector Control 
185.2uM 
harringtonine 102 0 0.0 
Experim
ent 12 hsf-1(sy441) Vector Control 
23.1uM 
harringtonine 129 18 12.2 
Experim
ent 12 hsf-1(sy441) Vector Control 
46.3uM 
harringtonine 98 16 14.0 
Experim
ent 12 hsf-1(sy441) Vector Control 
5.8uM 
harringtonine 130 15 10.3 
Experim
ent 12 hsf-1(sy441) Vector Control 
92.6uM 
harringtonine 112 14 11.1 
Experim
ent 12 hsf-1(sy441) Vector Control 
11.6uM 
harringtonine 101 14 12.2 
Experim
ent 12 hsf-1(sy441) Vector Control  54 91 62.8 
Experim
ent 12 
hsf-1(sy441); 
rsks-1(mu482) Vector Control 
92.6uM 
harringtonine 20 66 76.7 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 12 wild-type Vector Control 0.19% DMSO 0 66 100.0 
Experim
ent 12 wild-type Vector Control 
185.2uM 
harringtonine 2 110 98.2 
Experim
ent 12 wild-type Vector Control 
46.3uM 
harringtonine 0 91 100.0 
Experim
ent 12 wild-type Vector Control 
92.6uM 
harringtonine 0 69 100.0 
Experim
ent 13 hsf-1(sy441) Vector Control 0.012% DMSO 83 4 4.6 
Experim
ent 13 hsf-1(sy441) Vector Control 0.023% DMSO 65 14 17.7 
Experim
ent 13 hsf-1(sy441) Vector Control 0.046% DMSO 96 18 15.8 
Experim
ent 13 hsf-1(sy441) Vector Control 0.092% DMSO 77 15 16.3 
Experim
ent 13 hsf-1(sy441) Vector Control 0.19% DMSO 97 13 11.8 
Experim
ent 13 hsf-1(sy441) rsks-1 0.19%DMSO 68 23 25.3 
Experim
ent 13 hsf-1(sy441) Vector Control 0.37% DMSO 70 9 11.4 
Experim
ent 14 hsf-1(sy441) Vector Control 
3nM 
harringtonine 83 14 14.4 
Experim
ent 14 hsf-1(sy441) Vector Control 
6nM 
harringtonine 94 19 16.8 
Experim
ent 14 hsf-1(sy441) Vector Control 
11nM 
harringtonine 80 20 20.0 
Experim
ent 14 hsf-1(sy441) Vector Control 0.023% DMSO 77 27 26.0 
Experim
ent 14 hsf-1(sy441) rsks-1 0.023%DMSO 63 32 33.7 
Experim
ent 14 hsf-1(sy441) Vector Control 
23nM 
harringtonine 78 11 12.4 
Experim
ent 14 hsf-1(sy441) Vector Control 
45nM 
harringtonine 51 17 25.0 
Experim
ent 14 hsf-1(sy441) Vector Control 
90nM 
harringtonine 84 28 25.0 
Experim
ent 14 hsf-1(sy441) Vector Control 0.092% DMSO 99 22 18.2 
Experim
ent 14 hsf-1(sy441) Vector Control 
181nM 
harringtonine 55 25 31.3 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 14 hsf-1(sy441) Vector Control 0.19% DMSO 57 27 32.1 
Experim
ent 14 hsf-1(sy441) Vector Control 
362nM 
harringtonine 64 21 24.7 
Experim
ent 14 hsf-1(sy441) Vector Control 
723nM 
harringtonine 73 9 11.0 
Experim
ent 14 hsf-1(sy441) Vector Control 
1.4uM 
harringtonine 70 17 19.5 
Experim
ent 14 hsf-1(sy441) Vector Control 
2.9uM 
harringtonine 58 9 13.4 
Experim
ent 14 hsf-1(sy441) Vector Control H20 62 36 36.7 
Experim
ent 15 hsf-1(sy441) Vector Control 23nM salubrinal 71 33 31.7 
Experim
ent 15 hsf-1(sy441) Vector Control 0.046% DMSO 77 27 26.0 
Experim
ent 15 hsf-1(sy441) Vector Control 45nM salubrinal 68 38 35.8 
Experim
ent 15 hsf-1(sy441) Vector Control 0.092% DMSO 72 25 25.8 
Experim
ent 15 hsf-1(sy441) Vector Control 90nM salubrinal 78 38 32.8 
Experim
ent 15 hsf-1(sy441) rsks-1 0.19%DMSO 58 40 40.8 
Experim
ent 15 hsf-1(sy441) Vector Control 0.19%DMSO 85 25 22.7 
Experim
ent 15 hsf-1(sy441) Vector Control 
181nM 
salubrinal 80 24 23.1 
Experim
ent 15 hsf-1(sy441) Vector Control 
362nM 
salubrinal 97 50 34.0 
Experim
ent 15 hsf-1(sy441) Vector Control 
723nM 
salubrinal 108 20 15.6 
Experim
ent 15 hsf-1(sy441) Vector Control 
1.4uM 
salubrinal 58 15 20.5 
Experim
ent 15 hsf-1(sy441) Vector Control 
2.9uM 
salubrinal 78 18 18.8 
Experim
ent 15 hsf-1(sy441) Vector Control 
23.1uM 
salubrinal 127 1 0.8 
Experim
ent 15 hsf-1(sy441) Vector Control 
5.8uM 
salubrinal 71 21 22.8 
Experim
ent 15 hsf-1(sy441) Vector Control 
11.6uM 
salubrinal 97 2 2.0 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 15 hsf-1(sy441) Vector Control H2O 88 63 41.7 
Experim
ent 16 hsf-1(sy441) Vector Control 
3nM 
harringtonine 69 49 41.5 
Experim
ent 16 hsf-1(sy441) Vector Control 
6nM 
harringtonine 73 33 31.1 
Experim
ent 16 hsf-1(sy441) Vector Control 
11nM 
harringtonine 50 26 34.2 
Experim
ent 16 hsf-1(sy441) Vector Control 0.023% DMSO 82 25 23.4 
Experim
ent 16 hsf-1(sy441) rsks-1 0.023%DMSO 24 64 72.7 
Experim
ent 16 hsf-1(sy441) Vector Control 
23nM 
harringtonine 87 29 25.0 
Experim
ent 16 hsf-1(sy441) Vector Control 
45nM 
harringtonine 82 47 36.4 
Experim
ent 16 hsf-1(sy441) Vector Control 
90nM 
harringtonine 47 31 39.7 
Experim
ent 16 hsf-1(sy441) Vector Control 0.092% DMSO 98 36 26.9 
Experim
ent 16 hsf-1(sy441) Vector Control 
181nM 
harringtonine 43 31 41.9 
Experim
ent 16 hsf-1(sy441) Vector Control 0.19% DMSO 61 25 29.1 
Experim
ent 16 hsf-1(sy441) Vector Control 
362nM 
harringtonine 77 27 26.0 
Experim
ent 16 hsf-1(sy441) Vector Control 
723nM 
harringtonine 52 24 31.6 
Experim
ent 16 hsf-1(sy441) Vector Control 
1.4uM 
harringtonine 73 20 21.5 
Experim
ent 16 hsf-1(sy441) Vector Control 
2.9uM 
harringtonine 76 22 22.4 
Experim
ent 16 hsf-1(sy441) Vector Control H20 64 49 43.4 
Experim
ent 17 hsf-1(sy441) Vector Control 6nM salubrinal 122 47 27.8 
Experim
ent 17 hsf-1(sy441) Vector Control 6nM salubrinal 95 22 18.8 
Experim
ent 17 hsf-1(sy441) Vector Control 23nM salubrinal 83 28 25.2 
Experim
ent 17 hsf-1(sy441) Vector Control 23nM salubrinal 85 18 17.5 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 17 hsf-1(sy441) Vector Control 23nM salubrinal 94 22 19.0 
Experim
ent 17 hsf-1(sy441) Vector Control 0.19% DMSO 120 17 12.4 
Experim
ent 17 hsf-1(sy441) Vector Control 0.19% DMSO 118 47 28.5 
Experim
ent 17 hsf-1(sy441) Vector Control 0.19% DMSO 107 26 19.5 
Experim
ent 17 hsf-1(sy441) rsks-1 0.19%DMSO 54 66 55.0 
Experim
ent 17 hsf-1(sy441) Vector Control 
362nM 
salubrinal 82 18 18.0 
Experim
ent 17 hsf-1(sy441) Vector Control 
362nM 
salubrinal 106 43 28.9 
Experim
ent 17 hsf-1(sy441) Vector Control 
362nM 
salubrinal 130 6 4.4 
Experim
ent 17 hsf-1(sy441) Vector Control 
723nM 
salubrinal 96 39 28.9 
Experim
ent 17 hsf-1(sy441) Vector Control 
723nM 
salubrinal 112 29 20.6 
Experim
ent 17 hsf-1(sy441) Vector Control 
723nM 
salubrinal 131 20 13.2 
Experim
ent 17 hsf-1(sy441) Vector Control 
11.6uM 
salubrinal 110 1 0.9 
Experim
ent 17 hsf-1(sy441) Vector Control 
11.6uM 
salubrinal 70 1 1.4 
Experim
ent 18 hsf-1(sy441) Vector Control 
3nM 
harringtonine 51 8 13.6 
Experim
ent 18 hsf-1(sy441) Vector Control 
3nM 
harringtonine 36 10 21.7 
Experim
ent 18 hsf-1(sy441) Vector Control 
3nM 
harringtonine 43 11 20.4 
Experim
ent 18 hsf-1(sy441) Vector Control 0.023% DMSO 52 6 10.3 
Experim
ent 18 hsf-1(sy441) Vector Control 0.023% DMSO 39 8 17.0 
Experim
ent 18 hsf-1(sy441) Vector Control 0.023% DMSO 60 4 6.3 
Experim
ent 18 hsf-1(sy441) rsks-1 0.023%DMSO 29 10 25.6 
Experim
ent 18 hsf-1(sy441) rsks-1 0.023%DMSO 30 14 31.8 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 18 hsf-1(sy441) rsks-1 0.023%DMSO 36 10 21.7 
Experim
ent 18 hsf-1(sy441) Vector Control 
90nM 
harringtonine 52 8 13.3 
Experim
ent 18 hsf-1(sy441) Vector Control 
90nM 
harringtonine 42 7 14.3 
Experim
ent 18 hsf-1(sy441) Vector Control 
90nM 
harringtonine 53 0 0.0 
Experim
ent 18 hsf-1(sy441) Vector Control 
181nM 
harringtonine 43 5 10.4 
Experim
ent 18 hsf-1(sy441) Vector Control 
181nM 
harringtonine 54 2 3.6 
Experim
ent 18 hsf-1(sy441) Vector Control 
181nM 
harringtonine 40 9 18.4 
Experim
ent 18 hsf-1(sy441) Vector Control 
5.8uM 
harringtonine 51 1 1.9 
Experim
ent 18 hsf-1(sy441) Vector Control 
5.8uM 
harringtonine 56 2 3.4 
Experim
ent 18 hsf-1(sy441) Vector Control 
5.8uM 
harringtonine 40 2 4.8 
Experim
ent 19 hsf-1(sy441) Vector Control 
3nM 
harringtonine 73 27 27.0 
Experim
ent 19 hsf-1(sy441) Vector Control 
3nM 
harringtonine 103 12 10.4 
Experim
ent 19 hsf-1(sy441) Vector Control 
3nM 
harringtonine 113 10 8.1 
Experim
ent 19 hsf-1(sy441) Vector Control 0.023% DMSO 103 8 7.2 
Experim
ent 19 hsf-1(sy441) Vector Control 0.023% DMSO 68 24 26.1 
Experim
ent 19 hsf-1(sy441) Vector Control 0.023% DMSO 107 9 7.8 
Experim
ent 19 hsf-1(sy441) rsks-1 0.023% DMSO 82 53 39.3 
Experim
ent 19 hsf-1(sy441) rsks-1 0.023% DMSO 58 55 48.7 
Experim
ent 19 hsf-1(sy441) rsks-1 0.023% DMSO 80 10 11.1 
Experim
ent 19 hsf-1(sy441) Vector Control 
90nM 
harringtonine 107 15 12.3 
Experim
ent 19 hsf-1(sy441) Vector Control 
90nM 
harringtonine 107 15 12.3 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 19 hsf-1(sy441) Vector Control 
90nM 
harringtonine 99 20 16.8 
Experim
ent 19 hsf-1(sy441) Vector Control 
181nM 
harringtonine 96 8 7.7 
Experim
ent 19 hsf-1(sy441) Vector Control 
181nM 
harringtonine 90 6 6.3 
Experim
ent 19 hsf-1(sy441) Vector Control 
181nM 
harringtonine 93 13 12.3 
Experim
ent 19 hsf-1(sy441) Vector Control 
5.8uM 
harringtonine 81 6 6.9 
Experim
ent 19 hsf-1(sy441) Vector Control 
5.8uM 
harringtonine 94 4 4.1 
Experim
ent 19 hsf-1(sy441) Vector Control 
5.8uM 
harringtonine 127 7 5.2 
Experim
ent 20 hsf-1(sy441) Vector Control 6nM salubrinal 109 20 15.5 
Experim
ent 20 hsf-1(sy441) Vector Control 6nM salubrinal 88 23 20.7 
Experim
ent 20 hsf-1(sy441) Vector Control 6nM salubrinal 87 7 7.4 
Experim
ent 20 hsf-1(sy441) Vector Control 0.19% DMSO 72 10 12.2 
Experim
ent 20 hsf-1(sy441) Vector Control 0.19% DMSO 95 12 11.2 
Experim
ent 20 hsf-1(sy441) Vector Control 0.19% DMSO 142 20 12.3 
Experim
ent 20 hsf-1(sy441) rsks-1 0.19% DMSO 46 27 37.0 
Experim
ent 20 hsf-1(sy441) rsks-1 0.19% DMSO 80 34 29.8 
Experim
ent 20 hsf-1(sy441) rsks-1 0.19% DMSO 60 57 48.7 
Experim
ent 20 hsf-1(sy441) Vector Control 
362nM 
salubrinal 81 14 14.7 
Experim
ent 20 hsf-1(sy441) Vector Control 
362nM 
salubrinal 54 10 15.6 
Experim
ent 20 hsf-1(sy441) Vector Control 
362nM 
salubrinal 33 6 15.4 
Experim
ent 20 hsf-1(sy441) Vector Control 
723nM 
salubrinal 32 4 11.1 
Experim
ent 20 hsf-1(sy441) Vector Control 
723nM 
salubrinal 80 8 9.1 
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Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 20 hsf-1(sy441) Vector Control 
723nM 
salubrinal 128 16 11.1 
Experim
ent 20 hsf-1(sy441) Vector Control 
11.6uM 
salubrinal 123 1 0.8 
Experim
ent 20 hsf-1(sy441) Vector Control 
11.6uM 
salubrinal 74 2 2.6 
Experim
ent 20 hsf-1(sy441) Vector Control 
11.6uM 
salubrinal 139 5 3.5 
Experim
ent 21 hsf-1(sy441) Vector Control  79 23 22.5 
Experim
ent 21 hsf-1(sy441) rsks-1  44 32 42.1 
Experim
ent 21 hsf-1(sy441) rps-6 50%  63 0 0.0 
Experim
ent 21 hsf-1(sy441) rps-6 25%  95 4 4.0 
Experim
ent 21 hsf-1(sy441) Vector Control 0.19% DMSO 85 5 5.6 
Experim
ent 21 hsf-1(sy441) rsks-1 0.19% DMSO 71 37 34.3 
Experim
ent 21 hsf-1(sy441) Vector Control 
185.2uM 
harringtonine 92 1 1.1 
Experim
ent 22 hsf-1(sy441) Vector Control  65 49 43.0 
Experim
ent 22 hsf-1(sy441) rsks-1  46 81 63.8 
Experim
ent 22 hsf-1(sy441) rps-6 50%  98 0 0.0 
Experim
ent 22 hsf-1(sy441) rps-6 25%  93 4 4.1 
Experim
ent 22 hsf-1(sy441) Vector Control 0.19% DMSO 67 18 21.2 
Experim
ent 22 hsf-1(sy441) rsks-1 0.19% DMSO 30 42 58.3 
Experim
ent 23 hsf-1(sy441) Vector Control 
185.2uM 
harringtonine 64 0 0.0 
Experim
ent 23 hsf-1(sy441) Vector Control  50 23 31.5 
Experim
ent 23 hsf-1(sy441) rsks-1  36 46 56.1 
Experim
ent 23 hsf-1(sy441) rps-6 50%  91 2 2.2 
89 
 
Experim
ent # Genotype RNAi Drug Treatment 
# Animals 
that did 
not reach 
adulthood # Adults 
Percentage of 
Animals that 
Developed to 
Adulthood 
Experim
ent 23 hsf-1(sy441) rps-6 25%  91 6 6.2 
Experim
ent 23 hsf-1(sy441) Vector Control 0.19% DMSO 37 19 33.9 
Experim
ent 23 hsf-1(sy441) rsks-1 0.19% DMSO 28 28 50.0 
Experim
ent 23 hsf-1(sy441) Vector Control 
185.2uM 
harringtonine 61 0 0.0 
 
  
90 
 
Table 3.2: RNAi knockdown of many genes associated with mTOR, rsks-1, and hsf-1 failed to rescue the 
hsf-1(sy441) developmental arrest or failed to prevent the rsks-1(mu482) mutation from rescuing the 
hsf-1(sy441) developmental arrest. 
 
Experi
ment # Genotype RNAi 
RNAi 
Clon
e 
Seq-
uenc
ed? Comments 
# Animals 
that did 
not reach 
adulthood 
# 
Adults 
% 
Animals 
Develop
ed to 
Adultho
od 
Experi
ment 1 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  70 0 0.0 
Experi
ment 1 
hsf-1(sy441); 
rsks-1(mu482)  rsks-1 yes  5 102 95.3 
Experi
ment 1 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  1 120 99.2 
Experi
ment 1 hsf-1(sy441)  hsf-1 yes  76 0 0.0 
Experi
ment 1 hsf-1(sy441) Vector Control yes  73 6 7.6 
Experi
ment 1 hsf-1(sy441)  rsks-1 yes  49 52 51.5 
Experi
ment 1 wild-type  hsf-1 yes  8 70 89.7 
Experi
ment 1 wild-type Vector Control yes  0 64 100.0 
Experi
ment 1 wild-type  rsks-1 yes  0 138 100.0 
Experi
ment 2 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  1 69 98.6 
Experi
ment 2 hsf-1(sy441)  cco-1 yes  85 21 19.8 
Experi
ment 2 hsf-1(sy441)  daf-15 yes  61 41 40.2 
Experi
ment 2 hsf-1(sy441)  daf-2 yes  91 9 9.0 
Experi
ment 2 hsf-1(sy441)  hsb-1 yes  85 22 20.6 
Experi
ment 2 hsf-1(sy441) Vector Control yes  62 16 20.5 
Experi
ment 2 hsf-1(sy441)  ragc-1 yes  63 37 37.0 
Experi
ment 2 hsf-1(sy441)  rsks-1 yes  54 46 46.0 
Experi
ment 2 wild-type  cco-1 yes  6 39 86.7 
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Experi
ment # Genotype RNAi 
RNAi 
Clon
e 
Seq-
uenc
ed? Comments 
# Animals 
that did 
not reach 
adulthood 
# 
Adults 
% 
Animals 
Develop
ed to 
Adultho
od 
Experi
ment 2 wild-type  daf-15 yes  0 62 100.0 
Experi
ment 2 wild-type  daf-2 yes  0 68 100.0 
Experi
ment 2 wild-type  hsb-1 yes  0 64 100.0 
Experi
ment 2 wild-type Vector Control yes  0 65 100.0 
Experi
ment 2 wild-type  ragc-1 yes  0 122 100.0 
Experi
ment 2 wild-type  rsks-1 yes  0 71 100.0 
Experi
ment 3 
hsf-1(sy441); 
rsks-1(mu482)  daf-16 yes  0 75 100.0 
Experi
ment 3 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  41 42 50.6 
Experi
ment 3 
hsf-1(sy441); 
rsks-1(mu482)  hsp-4 yes  0 87 100.0 
Experi
ment 3 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  0 85 100.0 
Experi
ment 3 
hsf-1(sy441); 
rsks-1(mu482)  pha-4 yes  6 105 94.6 
Experi
ment 3 
hsf-1(sy441); 
rsks-1(mu482)  stc-1 yes  10 114 91.9 
Experi
ment 3 hsf-1(sy441) Vector Control yes  32 32 50.0 
Experi
ment 3 hsf-1(sy441)  rsks-1 yes  2 69 97.2 
Experi
ment 3 wild-type  hsf-1  yes  1 75 98.7 
Experi
ment 3 wild-type  hsp-4 yes  22 79 78.2 
Experi
ment 3 wild-type  pha-4 yes  2 63 96.9 
Experi
ment 3 wild-type  stc-1 yes  0 33 100.0 
Experi
ment 4 
hsf-1(sy441); 
rsks-1(mu482)  daf-16 yes  1 66 98.5 
Experi
ment 4 
hsf-1(sy441); 
rsks-1(mu482)  hif-1 yes  0 70 100.0 
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Experi
ment # Genotype RNAi 
RNAi 
Clon
e 
Seq-
uenc
ed? Comments 
# Animals 
that did 
not reach 
adulthood 
# 
Adults 
% 
Animals 
Develop
ed to 
Adultho
od 
Experi
ment 4 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  105 40 27.6 
Experi
ment 4 
hsf-1(sy441); 
rsks-1(mu482)  hsp-4 yes  8 70 89.7 
Experi
ment 4 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  2 155 98.7 
Experi
ment 4 
hsf-1(sy441); 
rsks-1(mu482)  pha-4 yes  0 23 100.0 
Experi
ment 4 
hsf-1(sy441); 
rsks-1(mu482)  rsks-1 yes  2 81 97.6 
Experi
ment 4 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  daf-16 yes  4 60 93.8 
Experi
ment 4 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  hsf-1 yes  71 0 0.0 
Experi
ment 4 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  hsp-4 yes  30 21 41.2 
Experi
ment 4 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato] 
 Vector 
Control yes  3 109 97.3 
Experi
ment 4 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  pha-4 yes  3 44 93.6 
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Experi
ment # Genotype RNAi 
RNAi 
Clon
e 
Seq-
uenc
ed? Comments 
# Animals 
that did 
not reach 
adulthood 
# 
Adults 
% 
Animals 
Develop
ed to 
Adultho
od 
Experi
ment 4 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  rsks-1 yes  3 53 94.6 
Experi
ment 4 hsf-1(sy441)  hif-1 yes  100 52 34.2 
Experi
ment 4 hsf-1(sy441)  hsf-1 yes  145 0 0.0 
Experi
ment 4 hsf-1(sy441) 
 Vector 
Control yes  74 44 37.3 
Experi
ment 4 hsf-1(sy441)  rsks-1 yes  36 129 78.2 
Experi
ment 4 wild-type  hif-1 yes  0 93 100.0 
Experi
ment 5 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  61 39 39.0 
Experi
ment 5 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  0 95 100.0 
Experi
ment 5 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  hsf-1 yes  120 0 0.0 
Experi
ment 5 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato] 
 Vector 
Control yes  1 105 99.1 
Experi
ment 5 hsf-1(sy441)  cco-1 yes  163 20 10.9 
Experi
ment 5 hsf-1(sy441)  daf-15 yes  90 24 21.1 
Experi
ment 5 hsf-1(sy441)  daf-2 yes  102 1 1.0 
Experi
ment 5 hsf-1(sy441)  hsb-1 yes  103 11 9.6 
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Experi
ment # Genotype RNAi 
RNAi 
Clon
e 
Seq-
uenc
ed? Comments 
# Animals 
that did 
not reach 
adulthood 
# 
Adults 
% 
Animals 
Develop
ed to 
Adultho
od 
Experi
ment 5 hsf-1(sy441)  hsf-1 yes  107 0 0.0 
Experi
ment 5 hsf-1(sy441) 
 Vector 
Control yes  94 15 13.8 
Experi
ment 5 hsf-1(sy441)  ragc-1 yes  81 49 37.7 
Experi
ment 5 hsf-1(sy441)  rsks-1 yes  51 79 60.8 
Experi
ment 5 wild-type  cco-1 yes  2 99 98.0 
Experi
ment 5 wild-type  hsf-1  yes  0 52 100.0 
Experi
ment 5 wild-type 
 Vector 
Control yes  0 69 100.0 
Experi
ment 6 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  35 15 30.0 
Experi
ment 6 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  0 37 100.0 
Experi
ment 6 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  daf-16 yes  0 125 100.0 
Experi
ment 6 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  hif-1 yes  0 105 100.0 
Experi
ment 6 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  hsf-1 yes  89 0 0.0 
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Experi
ment # Genotype RNAi 
RNAi 
Clon
e 
Seq-
uenc
ed? Comments 
# Animals 
that did 
not reach 
adulthood 
# 
Adults 
% 
Animals 
Develop
ed to 
Adultho
od 
Experi
ment 6 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  hsp-4 yes  24 24 50.0 
Experi
ment 6 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato] 
 Vector 
Control yes  0 119 100.0 
Experi
ment 6 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  pha-4 yes  0 86 100.0 
Experi
ment 6 hsf-1(sy441)  hsf-1 yes  231 1 0.4 
Experi
ment 6 hsf-1(sy441) 
 Vector 
Control yes  127 51 28.7 
Experi
ment 6 hsf-1(sy441)  rsks-1 yes  47 106 69.3 
Experi
ment 6 wild-type  hif-1 yes  0 144 100.0 
Experi
ment 7 
hsf-1(sy441); 
rsks-1(mu482)  cco-1 yes  6 173 96.6 
Experi
ment 7 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  78 81 50.9 
Experi
ment 7 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  0 178 100.0 
Experi
ment 7 hsf-1(sy441)  cco-1 yes  87 4 4.4 
Experi
ment 7 hsf-1(sy441)  daf-15 yes  80 15 15.8 
Experi
ment 7 hsf-1(sy441)  daf-2 yes  51 3 5.6 
Experi
ment 7 hsf-1(sy441)  hsb-1 yes  72 29 28.7 
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Experi
ment 7 hsf-1(sy441)  hsf-1 yes  85 1 1.2 
Experi
ment 7 hsf-1(sy441) 
 Vector 
Control yes  93 17 15.5 
Experi
ment 7 hsf-1(sy441)  ragc-1 yes  49 21 30.0 
Experi
ment 7 hsf-1(sy441)  rsks-1 yes  41 30 42.3 
Experi
ment 8 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  101 20 16.5 
Experi
ment 8 
hsf-1(sy441); 
rsks-1(mu482)  hsp-4 yes  2 113 98.3 
Experi
ment 8 
hsf-1(sy441); 
rsks-1(mu482)  hsp-6 yes  117 0 0.0 
Experi
ment 8 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  0 105 100.0 
Experi
ment 8 
hsf-1(sy441); 
rsks-1(mu482)  pat-10 yes  17 100 85.5 
Experi
ment 8 
hsf-1(sy441); 
rsks-1(mu482)  W04b5.5 yes  3 114 97.4 
Experi
ment 8 
hsf-1(sy441); 
rsks-1(mu482)  xbp-1 yes  29 94 76.4 
Experi
ment 8 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  hsf-1 yes  103 0 0.0 
Experi
ment 8 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  hsp-4 yes  22 98 81.7 
Experi
ment 8 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  hsp-6 yes  152 0 0.0 
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Experi
ment 8 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato] 
 Vector 
Control yes  1 133 99.3 
Experi
ment 8 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  pat-10 yes  81 33 28.9 
Experi
ment 8 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  W04b5.5  yes  0 141 100.0 
Experi
ment 8 
hsf-1(sy441); 
uthIs225[sur-
5p::hsf-
1(sy441); 
myo2p::tdTom
ato]  xbp-1 yes  2 106 98.1 
Experi
ment 8 hsf-1(sy441) 
 Vector 
Control yes  180 27 13.0 
Experi
ment 8 hsf-1(sy441)  rsks-1 yes  137 129 48.5 
Experi
ment 9 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  75 11 12.8 
Experi
ment 9 
hsf-1(sy441); 
rsks-1(mu482)  hsp-4 yes  7 102 93.6 
Experi
ment 9 
hsf-1(sy441); 
rsks-1(mu482)  hsp-6 yes  82 3 3.5 
Experi
ment 9 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  4 111 96.5 
Experi
ment 9 
hsf-1(sy441); 
rsks-1(mu482)  pat-10 yes  27 70 72.2 
Experi
ment 9 
hsf-1(sy441); 
rsks-1(mu482)  W04b5.5 yes  4 94 95.9 
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Experi
ment 9 
hsf-1(sy441); 
rsks-1(mu482)  xbp-1 yes  20 78 79.6 
Experi
ment 9 hsf-1(sy441) 
 Vector 
Control yes  114 12 9.5 
Experi
ment 9 hsf-1(sy441)  rsks-1 yes  84 44 34.4 
Experi
ment 9 wild-type  hsp-4 yes  0 133 100.0 
Experi
ment 9 wild-type  hsp-6 yes  42 2 4.5 
Experi
ment 9 wild-type 
 Vector 
Control yes  0 114 100.0 
Experi
ment 9 wild-type  pat-10 yes  96 19 16.5 
Experi
ment 9 wild-type  w04b5.5 yes  0 130 100.0 
Experi
ment 9 wild-type  xbp-1 yes  0 95 100.0 
Experi
ment 
10 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  38 9 19.1 
Experi
ment 
10 
hsf-1(sy441); 
rsks-1(mu482)  hsp-4 yes  1 51 98.1 
Experi
ment 
10 
hsf-1(sy441); 
rsks-1(mu482)  hsp-6 yes  42 0 0.0 
Experi
ment 
10 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  6 54 90.0 
Experi
ment 
10 
hsf-1(sy441); 
rsks-1(mu482)  pat-10 yes  27 22 44.9 
Experi
ment 
10 
hsf-1(sy441); 
rsks-1(mu482)  w04b5.5 yes  1 53 98.1 
Experi
ment 
10 
hsf-1(sy441); 
rsks-1(mu482)  xbp-1 yes  5 25 83.3 
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Experi
ment 
10 hsf-1(sy441) 
 Vector 
Control yes  111 15 11.9 
Experi
ment 
10 hsf-1(sy441)  rsks-1 yes  66 64 49.2 
Experi
ment 
10 wild-type  hsp-6 yes  66 0 0.0 
Experi
ment 
10 wild-type 
 Vector 
Control yes  0 104 100.0 
Experi
ment 
10 wild-type  pat-10 yes  89 30 25.2 
Experi
ment 
10 wild-type  w04b5.5 yes  0 93 100.0 
Experi
ment 
10 wild-type  xbp-1 yes  0 79 100.0 
Experi
ment 
11 
hsf-1(sy441); 
rsks-1(mu482)  ftt-2 yes  9 120 93.0 
Experi
ment 
11 
hsf-1(sy441); 
rsks-1(mu482) zipt-7.1 yes  1 134 99.3 
Experi
ment 
11 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  42 55 56.7 
Experi
ment 
11 
hsf-1(sy441); 
rsks-1(mu482)  hsp-60 yes  19 114 85.7 
Experi
ment 
11 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  3 84 96.6 
Experi
ment 
11 
hsf-1(sy441); 
rsks-1(mu482)  lin-12   0 91 100.0 
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Experi
ment 
11 
hsf-1(sy441); 
rsks-1(mu482)  pek-1 yes  0 91 100.0 
Experi
ment 
11 wild-type  ftt-2 yes  0 117 100.0 
Experi
ment 
11 wild-type zipt-7.1 yes  0 85 100.0 
Experi
ment 
11 wild-type  hsf-1 yes  0 78 100.0 
Experi
ment 
11 wild-type  hsp-60 yes  20 142 87.7 
Experi
ment 
11 wild-type 
 Vector 
Control yes  0 105 100.0 
Experi
ment 
11 wild-type  pek-1 yes  0 85 100.0 
Experi
ment 
12 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  31 37 54.4 
Experi
ment 
12 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  1 78 98.7 
Experi
ment 
12 
hsf-1(sy441); 
rsks-1(mu482)  rsks-1 yes  0 82 100.0 
Experi
ment 
12 hsf-1(sy441)  hsf-1 yes  99 2 2.0 
Experi
ment 
12 hsf-1(sy441) 
 Vector 
Control yes  73 11 13.1 
Experi
ment 
12 hsf-1(sy441)  rsks-1 yes  21 64 75.3 
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Experi
ment 
12 wild-type  hsf-1 yes  0 156 100.0 
Experi
ment 
12 wild-type 
 Vector 
Control yes  0 101 100.0 
Experi
ment 
12 wild-type  rsks-1 yes  1 114 99.1 
Experi
ment 
12 
rsks-
1(sv31)xhsf-
1(sy441)  hsf-1 yes  121 11 8.3 
Experi
ment 
12 
rsks-
1(sv31)xhsf-
1(sy441) 
 Vector 
Control yes  0 120 100.0 
Experi
ment 
12 
rsks-
1(sv31)xhsf-
1(sy441)  rsks-1 yes  0 127 100.0 
Experi
ment 
13 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp]  hsf-1 yes 
expressing 
extrachromosom
al array 41 10 19.6 
Experi
ment 
13 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp]  hsf-1 yes 
not expressing 
extrachromsomal 
array 51 17 25.0 
Experi
ment 
13 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp] 
 Vector 
Control yes 
expressing 
extrachromosom
al array 13 6 31.6 
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Experi
ment 
13 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp] 
 Vector 
Control yes 
expressing 
extrachromosom
al array 22 3 12.0 
Experi
ment 
13 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp] 
 Vector 
Control yes 
not expressing 
extrachromsomal 
array 6 103 94.5 
Experi
ment 
13 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp] 
 Vector 
Control yes 
not expressing 
extrachromsomal 
array 1 34 97.1 
Experi
ment 
13 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp]  rsks-1 yes 
expressing 
extrachromosom
al array 4 2 33.3 
Experi
ment 
13 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp]  rsks-1 yes 
not expressing 
extrachromsomal 
array 1 74 98.7 
Experi
ment 
13 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  61 22 26.5 
Experi
ment 
13 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  0 118 100.0 
Experi
ment 
13 hsf-1(sy441)  hsf-1 yes  76 0 0.0 
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Experi
ment 
13 hsf-1(sy441) 
 Vector 
Control yes  86 14 14.0 
Experi
ment 
13 hsf-1(sy441)  rsks-1 yes  44 71 61.7 
Experi
ment 
13 wild-type  hsf-1 yes  0 40 100.0 
Experi
ment 
13 wild-type 
 Vector 
Control yes  0 61 100.0 
Experi
ment 
13 
rsks-
1(sv31)xhsf-
1(sy441)  hsf-1 yes  82 5 5.7 
Experi
ment 
13 
rsks-
1(sv31)xhsf-
1(sy441) 
 Vector 
Control yes  0 82 100.0 
Experi
ment 
14 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp] 
 Vector 
Control yes 
expressing 
extrachromosom
al array, animals 
hatched from egg 
lay 22 1 4.3 
Experi
ment 
14 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp] 
 Vector 
Control yes 
not expressing 
extrachromsomal 
array, animals 
hatched from egg 
lay 2 39 95.1 
Experi
ment 
14 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp]  rsks-1 yes 
expressing 
extrachromosom
al array, animals 
hatched from egg 
lay 9 13 59.1 
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Experi
ment 
14 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp]  rsks-1 yes 
not expressing 
extrachromsomal 
array, animals 
hatched from egg 
lay 1 38 97.4 
Experi
ment 
14 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  73 49 40.2 
Experi
ment 
14 
hsf-1(sy441); 
rsks-1(mu482) 
 Vector 
Control yes  0 125 100.0 
Experi
ment 
14 hsf-1(sy441)  hsf-1 yes  197 3 1.5 
Experi
ment 
14 hsf-1(sy441) 
 Vector 
Control yes  136 44 24.4 
Experi
ment 
14 hsf-1(sy441)  rsks-1 yes  41 142 77.6 
Experi
ment 
14 wild-type  hsf-1 yes  0 80 100.0 
Experi
ment 
14 wild-type 
 Vector 
Control yes  0 98 100.0 
Experi
ment 
14 
rsks-
1(sv31)xhsf-
1(sy441)  hsf-1 yes  94 7 6.9 
Experi
ment 
14 
rsks-
1(sv31)xhsf-
1(sy441) 
 Vector 
Control yes  0 95 100.0 
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Experi
ment 
15 hsf-1(sy441)  C45H4.13  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 84 14 14.3 
Experi
ment 
15 hsf-1(sy441)  c54e4.9  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 85 12 12.4 
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Experi
ment 
15 hsf-1(sy441)  ckr-2  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 45 9 16.7 
Experi
ment 
15 hsf-1(sy441)  F21D9.8  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 71 5 6.6 
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Experi
ment 
15 hsf-1(sy441)  F33h12.6  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 70 22 23.9 
Experi
ment 
15 hsf-1(sy441)  F43D9.1  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 90 13 12.6 
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Experi
ment 
15 hsf-1(sy441)  H09603.2b  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 57 16 21.9 
Experi
ment 
15 hsf-1(sy441)  rsks-1 yes 
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 41 85 67.5 
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Experi
ment 
15 hsf-1(sy441)  srg-34  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 64 12 15.8 
Experi
ment 
15 hsf-1(sy441)  sri-43  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 68 8 10.5 
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Experi
ment 
15 hsf-1(sy441)  T07D10.1  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 75 8 9.6 
Experi
ment 
15 hsf-1(sy441)  T24A6.4  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 106 13 10.9 
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Experi
ment 
15 hsf-1(sy441)  T24F1.4  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 66 28 29.8 
Experi
ment 
15 hsf-1(sy441)  W09D6.4  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 71 19 21.1 
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Experi
ment 
15 hsf-1(sy441)  Y4358A.2  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 88 22 20.0 
Experi
ment 
15 hsf-1(sy441)  y43f8b.10  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 81 14 14.7 
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Experi
ment 
15 hsf-1(sy441)  Y49E10.10  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 114 33 22.4 
Experi
ment 
15 hsf-1(sy441)  ZK1010.5  
preliminary 
screen using 
RNAi to 
knockdown 
genes that were 
downregulated in 
rsks-1 mutant in 
hsf-1 to see if any 
rescued 
development. 
Only 2 plates per 
condition and no 
control strain 
(Vector Control 
was contam) 50 24 32.4 
Experi
ment 
16 hsf-1(sy441)  F33h12.6  
followup of 
preliminary 
screen with 4 
plates each 72 54 42.9 
Experi
ment 
16 hsf-1(sy441)  H09603.2b  
followup of 
preliminary 
screen with 4 
plates each 66 67 50.4 
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adulthood 
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Adults 
% 
Animals 
Develop
ed to 
Adultho
od 
Experi
ment 
16 hsf-1(sy441) 
 Vector 
Control yes 
followup of 
preliminary 
screen with 4 
plates each 71 56 44.1 
Experi
ment 
16 hsf-1(sy441)  rsks-1 yes 
followup of 
preliminary 
screen with 4 
plates each 11 100 90.1 
Experi
ment 
16 hsf-1(sy441)  T24F1.4  
followup of 
preliminary 
screen with 4 
plates each 26 75 74.3 
Experi
ment 
16 hsf-1(sy441)  W09D6.4  
followup of 
preliminary 
screen with 4 
plates each 46 64 58.2 
Experi
ment 
16 hsf-1(sy441)  Y4358A.2  
followup of 
preliminary 
screen with 4 
plates each 56 54 49.1 
Experi
ment 
16 hsf-1(sy441)  Y49E10.10  
followup of 
preliminary 
screen with 4 
plates each 56 50 47.2 
Experi
ment 
16 hsf-1(sy441)  ZK1010.5  
followup of 
preliminary 
screen with 4 
plates each 59 78 56.9 
Experi
ment 
17 hsf-1(sy441)  F33h12.6  
repeat of 
followup, 4 
plates each 95 44 31.7 
Experi
ment 
17 hsf-1(sy441) 
 Vector 
Control yes 
repeat of 
followup, 4 
plates each 54 37 40.7 
Experi
ment 
17 hsf-1(sy441)  rsks-1 yes 
repeat of 
followup, 4 
plates each 24 102 81.0 
Experi
ment 
17 hsf-1(sy441)  T24F1.4   
repeat of 
followup, 4 
plates each 77 49 38.9 
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Experi
ment 
17 hsf-1(sy441)  T24F1.4  
repeat of 
followup, 4 
plates each 53 42 44.2 
Experi
ment 
17 hsf-1(sy441)  Y4358A.2  
repeat of 
followup, 4 
plates each 91 45 33.1 
Experi
ment 
17 hsf-1(sy441)  ZK1010.5  
repeat of 
followup, 4 
plates each 78 57 42.2 
Experi
ment 
18 hsf-1(sy441)  aak-2 yes 
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 20 46 69.7 
Experi
ment 
18 hsf-1(sy441)  age-1  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 26 5 16.1 
Experi
ment 
18 hsf-1(sy441)  crb-1  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 29 23 44.2 
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Experi
ment 
18 hsf-1(sy441)  hke-4.2  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 19 11 36.7 
Experi
ment 
18 hsf-1(sy441)  hsp-70  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 37 10 21.3 
Experi
ment 
18 hsf-1(sy441)  jnk-1  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 19 30 61.2 
Experi
ment 
18 hsf-1(sy441)  k02b12  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 43 34 44.2 
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Experi
ment 
18 hsf-1(sy441) 
 Vector 
Control yes 
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 52 87 62.6 
Experi
ment 
18 hsf-1(sy441)  lgg-1 yes 
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 42 17 28.8 
Experi
ment 
18 hsf-1(sy441)  mnk-1  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 26 51 66.2 
Experi
ment 
18 hsf-1(sy441)  par-5  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 52 10 16.1 
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Experi
ment 
18 hsf-1(sy441)  phb-2  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 42 26 38.2 
Experi
ment 
18 hsf-1(sy441)  rheb-1  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 25 50 66.7 
Experi
ment 
18 hsf-1(sy441)  rsks-1 yes 
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 7 120 94.5 
Experi
ment 
18 hsf-1(sy441)  sek-1  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 35 31 47.0 
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Experi
ment 
18 hsf-1(sy441)  sgk-1  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 30 25 45.5 
Experi
ment 
18 hsf-1(sy441)  sma-4  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 19 48 71.6 
Experi
ment 
18 hsf-1(sy441)  stdh-1  
preliminary 
screen using 
RNAi to 
knockdown 
genes from the 
rsks-1 interactors 
of wormbase. 
Only 2 plates per 
condition 34 38 52.8 
Experi
ment 
19 
hsf-1(sy441); 
rsks-1(mu482)  hif-1 yes  0 76 100.0 
Experi
ment 
19 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  48 52 52.0 
Experi
ment 
19 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  0 138 100.0 
Experi
ment 
19 
hsf-1(sy441); 
rsks-1(mu482)  skn-1 yes  1 136 99.3 
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Experi
ment 
19 hsf-1(sy441) Vector Control yes  100 35 25.9 
Experi
ment 
19 hsf-1(sy441) OP50  
op50 grown for a 
few days from 
stationary phase 46 69 60.0 
Experi
ment 
19 hsf-1(sy441) OP50  
op50 grown by 
RNAi bacteria 
protocol 60 45 42.9 
Experi
ment 
19 hsf-1(sy441)  rsks-1 yes  45 119 72.6 
Experi
ment 
19 hsf-1(sy441)  T24F1.4   96 38 28.4 
Experi
ment 
19 
hsf-
1(sy441)xT24F
1.4(tm5213) Vector Control yes  125 36 22.4 
Experi
ment 
19 
hsf-
1(sy441)xT24F
1.4(tm5213) OP50   45 5 10.0 
Experi
ment 
19 
hsf-
1(sy441)xT24F
1.4(tm5213)  rsks-1 yes  58 57 49.6 
Experi
ment 
19 
hsf-
1(sy441)xT24F
1.4(tm5397) Vector Control yes  101 10 9.0 
Experi
ment 
19 wild-type  hif-1 yes  0 124 100.0 
Experi
ment 
19 wild-type Vector Control yes  0 90 100.0 
Experi
ment 
19 wild-type  skn-1 yes  0 147 100.0 
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Experi
ment 
20 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp] Vector Control yes 
expressing 
extrachromosom
al array 36 1 2.7 
Experi
ment 
20 
hsf-1(sy441); 
rsks-
1(mu482); 
svEx136[unc-
36(+) rsks-1(+) 
sur-5::gfp] Vector Control yes 
not expressing 
extrachromsomal 
array 0 133 100.0 
Experi
ment 
21 
hsf-1(sy441); 
rsks-1(mu482)  gcs-1   2 90 97.8 
Experi
ment 
21 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  0 85 100.0 
Experi
ment 
21 hsf-1(sy441)  hif-1 yes  68 29 29.9 
Experi
ment 
21 hsf-1(sy441) Vector Control yes  62 41 39.8 
Experi
ment 
21 hsf-1(sy441)  rsks-1 yes  29 57 66.3 
Experi
ment 
21 hsf-1(sy441)  skn-1 yes  59 37 38.5 
Experi
ment 
21 wild-type  gcs-1   0 145 100.0 
Experi
ment 
21 wild-type Vector Control yes  0 135 100.0 
Experi
ment 
22 
hsf-1(sy441); 
rsks-1(mu482)  cct-2 yes  27 126 82.4 
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Experi
ment 
22 
hsf-1(sy441); 
rsks-1(mu482)  ced-1   0 127 100.0 
Experi
ment 
22 
hsf-1(sy441); 
rsks-1(mu482)  gsk-3 yes  3 115 97.5 
Experi
ment 
22 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  37 77 67.5 
Experi
ment 
22 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes 
0% developed is 
not normal. 
Could vector 
have been 
contaminated? 105 0 0.0 
Experi
ment 
22 
hsf-1(sy441); 
rsks-1(mu482)  pfs-2 yes  74 56 43.1 
Experi
ment 
22 hsf-1(sy441)  cct-2 yes  85 0 0.0 
Experi
ment 
22 hsf-1(sy441)  crh-1 yes  117 32 21.5 
Experi
ment 
22 hsf-1(sy441)  hrp-2 yes  57 47 45.2 
Experi
ment 
22 hsf-1(sy441) Vector Control yes 
0% developed is 
not normal. 
Could vector 
have been 
contaminated? 95 0 0.0 
Experi
ment 
22 hsf-1(sy441)  nhr-14 yes  85 47 35.6 
Experi
ment 
22 hsf-1(sy441)  nhr-91 yes  32 58 64.4 
Experi
ment 
22 hsf-1(sy441)  rsks-1 yes  22 81 78.6 
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Experi
ment 
22 hsf-1(sy441)  tiar-1 yes  56 52 48.1 
Experi
ment 
22 hsf-1(sy441)  Y55F3AM.3 yes  77 73 48.7 
Experi
ment 
23 
hsf-1(sy441); 
rsks-1(mu482)  cct-2 yes  15 55 78.6 
Experi
ment 
23 
hsf-1(sy441); 
rsks-1(mu482)  crh-1 yes  2 109 98.2 
Experi
ment 
23 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  49 50 50.5 
Experi
ment 
23 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  7 111 94.1 
Experi
ment 
23 
hsf-1(sy441); 
rsks-1(mu482)  nhr-14 yes  0 116 100.0 
Experi
ment 
23 
hsf-1(sy441); 
rsks-1(mu482)  pfs-2 yes  68 31 31.3 
Experi
ment 
23 hsf-1(sy441) Vector Control yes  66 36 35.3 
Experi
ment 
23 hsf-1(sy441)  nhr-10 yes  44 22 33.3 
Experi
ment 
23 hsf-1(sy441)  nhr-91 yes  45 20 30.8 
Experi
ment 
23 hsf-1(sy441)  rsks-1 yes  27 28 50.9 
Experi
ment 
23 hsf-1(sy441)  tiar-1 yes  77 34 30.6 
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Experi
ment 
23 wild-type  cct-2 yes  35 97 73.5 
Experi
ment 
23 wild-type 
 Vector 
Control yes  0 108 100.0 
Experi
ment 
23 wild-type  pfs-2 yes  4 104 96.3 
Experi
ment 
24 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  135 185 57.8 
Experi
ment 
24 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  100 214 68.2 
Experi
ment 
24 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  71 137 65.9 
Experi
ment 
24 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  6 341 98.3 
Experi
ment 
24 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  17 309 94.8 
Experi
ment 
24 
hsf-1(sy441); 
rsks-1(mu482)  pha-4 yes  8 163 95.3 
Experi
ment 
24 
hsf-1(sy441); 
rsks-1(mu482)  skn-1 yes  4 244 98.4 
Experi
ment 
24 
hsf-1(sy441); 
rsks-1(mu482)  skn-1 yes  9 195 95.6 
Experi
ment 
24 
hsf-1(sy441); 
rsks-1(mu482)  skn-1 yes  10 351 97.2 
Experi
ment 
24 hsf-1(sy441) Vector Control yes  70 40 36.4 
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Experi
ment 
24 hsf-1(sy441)  rsks-1 yes  47 47 50.0 
Experi
ment 
24 hsf-1(sy441)  skn-1 yes  44 55 55.6 
Experi
ment 
24 Wild Type  pha-4 yes  39 96 71.1 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  40 55 57.9 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  32 49 60.5 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482)  hsf-1 yes  42 66 61.1 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  7 147 95.5 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  0 88 100.0 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  7 95 93.1 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  0 135 100.0 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482)  pha-4 yes  3 98 97.0 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482)  pha-4 yes  0 107 100.0 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482)  pha-4 yes  3 115 97.5 
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Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482)  skn-1 yes  1 105 99.1 
Experi
ment 
25 
hsf-1(sy441); 
rsks-1(mu482)  skn-1 yes  3 111 97.4 
Experi
ment 
25 hsf-1(sy441) Vector Control yes  58 83 58.9 
Experi
ment 
25 hsf-1(sy441) Vector Control yes  45 51 53.1 
Experi
ment 
25 hsf-1(sy441) Vector Control yes  24 52 68.4 
Experi
ment 
25 hsf-1(sy441)  rsks-1 yes  32 96 75.0 
Experi
ment 
25 hsf-1(sy441)  rsks-1 yes  39 99 71.7 
Experi
ment 
25 hsf-1(sy441)  rsks-1 yes  22 49 69.0 
Experi
ment 
25 wild-type  pha-4 yes  3 118 97.5 
Experi
ment 
26 rsks-1(mu482) Vector Control yes  4 130 97.0 
Experi
ment 
26 hsf-1(sy441) rict-1 yes  26 26 50 
Experi
ment 
26 rsks-1(mu482) atg-18 yes  0 75 100 
Experi
ment 
26 
hsf-1(sy441); 
rsks-1(mu482) Vector Control yes  3 31 91.2 
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Experi
ment 
26 
hsf-1(sy441); 
rsks-1(mu482) lgg-1 yes  4 48 92.3 
Experi
ment 
26 hsf-1(sy441) rsks-1 yes  12 62 83.78 
Experi
ment 
26 rsks-1(mu482) hsf-1 yes  7 81 92.04 
Experi
ment 
26 rsks-1(mu482) lgg-1 yes  4 134 97.10 
Experi
ment 
26 
hsf-1(sy441); 
rsks-1(mu482) aak-2 yes  0 40 100 
Experi
ment 
26 rsks-1(mu482) argk-1 yes  4 104 96.3 
Experi
ment 
26 
hsf-1(sy441); 
rsks-1(mu482) argk-1 yes  4 55 93.2 
Experi
ment 
26 rsks-1(mu482) aak-2 yes  1 94 98.9 
Experi
ment 
26 hsf-1(sy441) Vector Control yes  46 41 47.1 
Experi
ment 
27 hsf-1(sy441) Vector Control yes  109 52 32.3 
Experi
ment 
27 hsf-1(sy441) rict-1 yes  119 63 34.6 
Experi
ment 
27 hsf-1(sy441) rsks-1 yes  63 63 50.0 
Experi
ment 
28 hsf-1(sy441) Vector Control yes  61 35 36.5 
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Experi
ment 
28 hsf-1(sy441) rict-1 yes  105 28 21.1 
Experi
ment 
28 hsf-1(sy441) rsks-1 yes  49 28 36.4 
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Table 3.3: RT-qPCR primer sequences  
Gene Name Forward Primer Reverse Primer Reference 
tba-1 
GTACACTCCACTGATCTCTGCTGA
CAAG 
CTCTGTACAAGAGGCAAACAGC
CATG 
Hoogewijs et al. 
2008 
cdc-42 CTGCTGGACAGGAAGATTACG CTCGGACATTCTCGAATGAAG 
Hoogewijs et al. 
2008 
pmp-3 GTTCCCGTGTTCATCACTCAT ACACCGTCGAGAAGCTGTAGA 
Hoogewijs et al. 
2008 
Hsp-4 AGATGCCGCCAAGAATCAGC TCGACGATCTTGAACGGCCAG  
Hsp-6 CGTGGTGTTCCACAAGTCGAG TCCTCAGCGGCATTCTTTTCG  
hsf-1 TTTGCATTTTCTCGTCTCTGTC TCTATTTCCAGCACACCTCGT Baird et al. 2014 
hsp-16.2 
TCCATCTGAGTCTTCTGAGATTGT
TA 
TGGTTTAAACTGTGAGACGTTG
A Baird et al. 2014 
F44E5.4 (hsp-
70)  TGCACCAATCTGGACAATCT TCCAGCAGTTCCAGGATTTC Baird et al. 2014 
dnj-13 ACGATGTCATTAAGCCGGG GAGTTGGATTGAGTTGTGATGG Li et al. 2016 
sti-1 CATGTTCACTACGACAAAGCG TCCAACTTCGACGGCTTTC Li et al. 2016 
hsp-60 CGCCGTCTCTGTCACTATG 
AGGTTCTGGTATTTGTCCTTGA
G Li et al. 2016 
hsp-110 ACTATTCTCTGCATGCCACTC 
GGATCACTGAATTTTCGTCCAAT
C Li et al. 2016 
  
130 
 
 
 
Publishing Agreement 
It is the policy of the University to encourage the distribution of all theses, dissertations, and 
manuscripts. Copies of all UCSF theses, dissertations, and manuscripts will be routed to the 
library via the Graduate Division. The library will make all theses, dissertations, and 
manuscripts accessible to the public and will preserve these to the best of their abilities, in 
perpetuity. 
I hereby grant permission to the Graduate Division of the University of California, San 
Francisco to release copies of my thesis, dissertation, or manuscript to the Campus Library 
to provide access and preservation, in whole or in part, in perpetuity. 
 
 
Author Signature ______________________________ Date __11-16-2018____________ 
 
 
 
